YSK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T455 | Sugiyama | SHTN1 KIAA1598 | KPESSKGCEsAVDELKGILGtLNKSTSSRsLKsLDPENsEt |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| O00303 | T119 | Sugiyama | EIF3F EIF3S5 | LASIVDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPH |
| O00303 | T123 | Sugiyama | EIF3F EIF3S5 | VDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPHNEsE |
| O00506 | S12 | Sugiyama | STK25 SOK1 YSK1 | _________MAHLRGFANQHsRVDPEELFTKLDRIGKGsFG |
| O00506 | S133 | Sugiyama | STK25 SOK1 YSK1 | EETYIATILREILKGLDYLHsERKIHRDIKAANVLLsEQGD |
| O00506 | S30 | Sugiyama | STK25 SOK1 YSK1 | QHsRVDPEELFTKLDRIGKGsFGEVYKGIDNHTKEVVAIKI |
| O00506 | S341 | Sugiyama | STK25 SOK1 YSK1 | FPPTIRPSPHSKLHKGtALHssQKPAEPVKRQPRSQCLSTL |
| O00506 | S342 | Sugiyama | STK25 SOK1 YSK1 | PPTIRPSPHSKLHKGtALHssQKPAEPVKRQPRSQCLSTLV |
| O00506 | S391 | Sugiyama | STK25 SOK1 YSK1 | EKHKQSGGSVGALEELENAFsLAEEsCPGISDKLMVHLVER |
| O00506 | S396 | Sugiyama | STK25 SOK1 YSK1 | SGGSVGALEELENAFsLAEEsCPGISDKLMVHLVERVQRFS |
| O00506 | T166 | Sugiyama | STK25 SOK1 YSK1 | VLLsEQGDVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEV |
| O00506 | T168 | Sugiyama | STK25 SOK1 YSK1 | LsEQGDVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIK |
| O00506 | T174 | GPS6|EPSD | STK25 SOK1 YSK1 | VKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIKQSAYDF |
| O00506 | T337 | Sugiyama | STK25 SOK1 YSK1 | PIWTFPPTIRPSPHSKLHKGtALHssQKPAEPVKRQPRSQC |
| O14818 | S150 | Sugiyama | PSMA7 HSPC | SALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVRE |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T509 | Sugiyama | ACTN4 | HNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAIDQL |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | S232 | Sugiyama | CTNND1 KIAA0384 | GysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRAPs |
| O75116 | T967 | Sugiyama | ROCK2 KIAA0619 | ELEIKEMMARHKQELTEKDAtIAsLEETNRtLtSDVANLAN |
| O75116 | T977 | Sugiyama | ROCK2 KIAA0619 | HKQELTEKDAtIAsLEETNRtLtSDVANLANEKEELNNKLK |
| O75821 | S217 | Sugiyama | EIF3G EIF3S4 | PGELEPVQAtQNKtGKYVPPsLRDGAsRRGESMQPNRRADD |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95218 | T50 | Sugiyama | ZRANB2 ZIS ZNF265 | SCNRCGREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQ |
| O95218 | T55 | Sugiyama | ZRANB2 ZIS ZNF265 | GREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQCKTCs |
| O95373 | T997 | Sugiyama | IPO7 RANBP7 | yQALTHGLNEEQRKQLQDIAtLADQRRAAHESKMIEKHGGY |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00390 | T507 | Sugiyama | GSR GLUR GRD1 | MLQGFAVAVKMGATKADFDNtVAIHPtssEELVtLR_____ |
| P00390 | T520 | Sugiyama | GSR GLUR GRD1 | TKADFDNtVAIHPtssEELVtLR__________________ |
| P00491 | T177 | Sugiyama | PNP NP | DRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVAG |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P02786 | T336 | Sugiyama | TFRC | FNHTQFPPSRSSGLPNIPVQtISRAAAEKLFGNMEGDCPSD |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T43 | Sugiyama | CAT | KADVLttGAGNPVGDKLNVItVGPRGPLLVQDVVFTDEMAH |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T124 | Sugiyama | ALDOA ALDA | VVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGAD |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04083 | T64 | Sugiyama | ANXA1 ANX1 LPC1 | PssDVAALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAY |
| P04083 | T70 | Sugiyama | ANXA1 ANX1 LPC1 | ALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAYLQEtGK |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04632 | T143 | Sugiyama | CAPNS1 CAPN4 CAPNS | ILNKVVTRHPDLKTDGFGIDtCRSMVAVMDSDTTGKLGFEE |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06703 | S46 | Sugiyama | S100A6 CACY | KHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRNKDQ |
| P06703 | T43 | Sugiyama | S100A6 CACY | EGDKHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRN |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06744 | S247 | Sugiyama | GPI | EWFLQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFW |
| P06744 | T250 | Sugiyama | GPI | LQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFWDWV |
| P06748 | S260 | Sugiyama | NPM1 NPM | GPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKNCFRMtD |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | S26 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07814 | S330 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KHRKNPIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGC |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07858 | T218 | Sugiyama | CTSB CPSB | CTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKD |
| P07858 | T95 | Sugiyama | CTSB CPSB | TEDLKLPAsFDAREQWPQCPtIKEIRDQGSCGSCWAFGAVE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | S72 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQDRtLtIV |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08195 | S253 | Sugiyama | SLC3A2 MDU1 | FQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDVA |
| P08195 | T321 | Sugiyama | SLC3A2 MDU1 | SIRVILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAG |
| P08195 | T325 | Sugiyama | SLC3A2 MDU1 | ILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAGVDGF |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S67 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERtLtLV |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T33 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | PGFDERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEI |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S360 | Sugiyama | HNRNPA1 HNRPA1 | PyGGGGQyFAKPRNQGGyGGssssssyGsGRRF________ |
| P09651 | S363 | Sugiyama | HNRNPA1 HNRPA1 | GGGQyFAKPRNQGGyGGssssssyGsGRRF___________ |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | Y357 | Sugiyama | HNRNPA1 HNRPA1 | ssGPyGGGGQyFAKPRNQGGyGGssssssyGsGRRF_____ |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10644 | S77 | PSP | PRKAR1A PKR1 PRKAR1 TSE1 | LEKEEAKQIQNLQKAGtRtDsREDEIsPPPPNPVVKGRRRR |
| P10644 | S83 | PSP | PRKAR1A PKR1 PRKAR1 TSE1 | KQIQNLQKAGtRtDsREDEIsPPPPNPVVKGRRRRGAIsAE |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T206 | Sugiyama | HSPD1 HSP60 | IsDAMKKVGRKGVITVKDGKtLNDELEIIEGMKFDRGyIsP |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P11142 | S153 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | AyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNVLRII |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T158 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | tVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11586 | T527 | Sugiyama | MTHFD1 MTHFC MTHFD | PTTLtDEEINRFARLDIDPEtITWQRVLDTNDRFLRKITIG |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12277 | S128 | Sugiyama | CKB CKBB | TDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsR |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T19 | Sugiyama | ENO3 | __MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | S445 | Sugiyama | PRKCSH G19P1 | YRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKy |
| P14314 | S451 | Sugiyama | PRKCSH G19P1 | KLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQGtGC |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T454 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SGRSAHQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLC |
| P14618 | T459 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | HQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLCKDPVQ |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T80 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T450 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRKTLD |
| P15153 | T161 | Sugiyama | RAC2 | QGLALAKEIDSVKyLECsALtQRGLKtVFDEAIRAVLCPQP |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16083 | T59 | Sugiyama | NQO2 NMOR2 | VSDLyAMNLEPRATDKDITGtLSNPEVFNyGVEtHEAyKQR |
| P16083 | T72 | Sugiyama | NQO2 NMOR2 | TDKDITGtLSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKV |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17174 | S106 | Sugiyama | GOT1 | RLALGDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNG |
| P17174 | T110 | Sugiyama | GOT1 | GDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNGTNNK |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18124 | T170 | Sugiyama | RPL7 | VNELIyKRGYGKINKKRIALtDNALIARSLGKyGIICMEDL |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S595 | Sugiyama | NCL | FVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKGFGFV |
| P19338 | T587 | Sugiyama | NCL | RSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETG |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | T600 | Sugiyama | UBA1 A1S9T UBE1 | ARMYMDRRCVYYRKPLLESGtLGtKGNVQVVIPFLTESySS |
| P22314 | T603 | Sugiyama | UBA1 A1S9T UBE1 | YMDRRCVYYRKPLLESGtLGtKGNVQVVIPFLTESySSSQD |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22626 | S201 | Sugiyama | HNRNPA2B1 HNRPA2B1 | NAEVRKALsRQEMQEVQssRsGRGGNFGFGDsRGGGGNFGP |
| P23193 | T256 | Sugiyama | TCEA1 GTF2S TFIIS | MRKNLTKEAIREHQMAKTGGtQTDLFtCGKCKKKNCTYTQV |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23526 | T157 | Sugiyama | AHCY SAHH | NLIHTKYPQLLPGIRGIsEEtTTGVHNLyKMMANGILKVPA |
| P23526 | T185 | Sugiyama | AHCY SAHH | yKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGIKR |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P25205 | S34 | Sugiyama | MCM3 | EAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVNDL |
| P25205 | T240 | Sugiyama | MCM3 | ILDDDLVDKAKPGDRVQVVGtYRCLPGKKGGYTSGTFRTVL |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | T248 | Sugiyama | TARS1 TARS | AMFKYNKFKCRILNEKVNtPtttVyRCGPLIDLCRGPHVRH |
| P26639 | T249 | Sugiyama | TARS1 TARS | MFKYNKFKCRILNEKVNtPtttVyRCGPLIDLCRGPHVRHT |
| P26639 | T657 | Sugiyama | TARS1 TARS | VRQQFHDAKFMADIDLDPGCtLNKKIRNAQLAQYNFILVVG |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | S66 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | EDPPDQKtsPsGKPAtLKICsWNVDGLRAWIKKKGLDWVKE |
| P27797 | S35 | Sugiyama | CALR CRTC | AVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssGK |
| P27797 | S40 | Sugiyama | CALR CRTC | AVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssGKFyGDE |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30040 | T43 | Sugiyama | ERP29 C12orf8 ERP28 | LLSAPHGGSGLHTKGALPLDtVtFyKVIPKSKFVLVKFDtQ |
| P30043 | S198 | Sugiyama | BLVRB FLR SCAN | KHDLGHFMLRCLttDEyDGHstyPsHQyQ____________ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P31327 | T903 | Sugiyama | CPS1 | DILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKCLGL |
| P31942 | S298 | Sugiyama | HNRNPH3 HNRPH3 | GGsGMGGYGRDGMDNQGGyGsVGRMGMGNNysGGyGtPDGL |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P32969 | T186 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | TVKNKDIRKFLDGIyVsEKGtVQQADE______________ |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T266 | Sugiyama | RPL4 RPL1 | VGRFCIWtEsAFRKLDELyGtWRKAAsLKsNyNLPMHKMIN |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T192 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | MKMKEtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIs |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | S93 | Sugiyama | RPS19 | GsMTKIYGGRQRNGVMPsHFsRGsKsVARRVLQALEGLKMV |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40926 | T224 | Sugiyama | MDH2 | TIIPLISQCtPKVDFPQDQLtALtGRIQEAGtEVVKAKAGA |
| P40926 | T227 | Sugiyama | MDH2 | PLISQCtPKVDFPQDQLtALtGRIQEAGtEVVKAKAGAGsA |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46779 | T89 | Sugiyama | RPL28 | GQRKPAtsyVRttINKNARAtLsSIRHMIRKNKYRPDLRMA |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49368 | T373 | Sugiyama | CCT3 CCTG TRIC5 | KKIGDEYFTFITDCKDPKACtILLRGAsKEILSEVERNLQD |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P49773 | T17 | Sugiyama | HINT1 HINT PKCI1 PRKCNH1 | ____MADEIAKAQVARPGGDtIFGKIIRKEIPAKIIFEDDR |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P54136 | T383 | Sugiyama | RARS1 RARS | IVFVPGCSIPLTIVKsDGGytyDtSDLAAIKQRLFEEKADM |
| P54136 | T386 | Sugiyama | RARS1 RARS | VPGCSIPLTIVKsDGGytyDtSDLAAIKQRLFEEKADMIIY |
| P54136 | Y384 | Sugiyama | RARS1 RARS | VFVPGCSIPLTIVKsDGGytyDtSDLAAIKQRLFEEKADMI |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P55209 | T64 | Sugiyama | NAP1L1 NRP | QNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNL |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P56192 | S812 | Sugiyama | MARS1 MARS | GHQIGTVSPLFQKLENDQIEsLRQRFGGGQAKtsPKPAVVE |
| P56192 | T710 | Sugiyama | MARS1 MARS | QHYHQLLEKVRIRDALRSILtISRHGNQyIQVNEPWKRIKG |
| P57721 | S59 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EGGLNVTLTIRLLMHGKEVGsIIGKKGETVKKMREESGARI |
| P57723 | S31 | Sugiyama | PCBP4 | EPELSITLTLRMLMHGKEVGsIIGKKGETVKRIREQSSARI |
| P60174 | S195 | Sugiyama | TPI1 TPI | KtATPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtG |
| P60174 | S204 | Sugiyama | TPI1 TPI | EVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60763 | T161 | Sugiyama | RAC3 | QGLAMAREIGSVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P61204 | S147 | Sugiyama | ARF3 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61254 | T94 | Sugiyama | RPL26 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61313 | Y59 | Sugiyama | RPL15 EC45 TCBAP0781 | APRPTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGA |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61927 | T82 | Sugiyama | RPL37 | GRMRHLKIVYRRFRHGFREGttPKPKRAAVAASSss_____ |
| P61927 | T83 | Sugiyama | RPL37 | RMRHLKIVYRRFRHGFREGttPKPKRAAVAASSss______ |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62191 | T56 | Sugiyama | PSMC1 | KKKKTKGPDAASKLPLVtPHtQCRLKLLKLERIKDYLLMEE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62241 | S66 | Sugiyama | RPS8 OK/SW-cl.83 | VRVRGGNKKYRALRLDVGNFsWGSECCTRKTRIIDVVyNAS |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | S67 | Sugiyama | RPS11 | PKEAIEGtyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIV |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T144 | Sugiyama | RPL7A SURF-3 SURF3 | GKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPI |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T24 | Sugiyama | RAN ARA24 OK/SW-cl.81 | QGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLG |
| P62826 | T25 | Sugiyama | RAN ARA24 OK/SW-cl.81 | GEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGV |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62847 | S78 | Sugiyama | RPS24 | FGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYE |
| P62888 | T83 | Sugiyama | RPL30 | yAMLAKtGVHHysGNNIELGtACGKyyRVCtLAIIDPGDsD |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62942 | T15 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______MGVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGK |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63000 | T161 | Sugiyama | RAC1 TC25 MIG5 | QGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | S58 | iPTMNet|EPSD | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T22 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T103 | Sugiyama | CCT2 99D8.1 CCTB | VLVDMSRVQDDEVGDGTTsVtVLAAELLREAESLIAKKIHP |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P78417 | Y27 | Sugiyama | GSTO1 GSTTLP28 | RsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLKAKGI |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84077 | S147 | Sugiyama | ARF1 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00341 | T729 | Sugiyama | HDLBP HBP VGL | VEKAKKQLLHLAEEKQTKSFtVDIRAKPEYHKFLIGKGGGK |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | Y110 | Sugiyama | RPL18A | tHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIMKVE |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T22 | Sugiyama | EEF1A2 EEF1AL STN | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T111 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | PKKQGGLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T39 | Sugiyama | RPL18 | KSQDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T79 | Sugiyama | RPL18 | PPLsLsRMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLK |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q12906 | T188 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | TIHLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALA |
| Q12965 | S943 | Sugiyama | MYO1E MYO1C | GLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGyHQ |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14157 | T23 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSVGTNRARGNWEQPQNQNQtQHKQRPQATAEQIRLAQMIS |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | S113 | Sugiyama | CTTN EMS1 | DRMDKsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVD |
| Q14498 | T175 | Sugiyama | RBM39 HCC1 RNPC2 | VFCMQLAARIRPRDLEEFFStVGKVRDVRMISDRNSRRSKG |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14677 | T271 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAAA |
| Q14683 | S514 | Sugiyama | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | SSRQQRKAEIMESIKRLYPGsVyGRLIDLCQPTQKKYQIAV |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15181 | T246 | Sugiyama | PPA1 IOPPP PP | HWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDAL |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | T163 | Sugiyama | RCN1 RCN | AtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAADLNGD |
| Q15365 | S27 | Sugiyama | PCBP1 | ESGLNVTLTIRLLMHGKEVGsIIGKKGESVKRIREEsGARI |
| Q15366 | S27 | Sugiyama | PCBP2 | EGGLNVTLTIRLLMHGKEVGsIIGKKGESVKKMREESGARI |
| Q15369 | T41 | Sugiyama | ELOC TCEB1 | LISSDGHEFIVKREHALtsGtIKAMLSGPGQFAENETNEVN |
| Q15459 | S508 | Sugiyama | SF3A1 SAP114 | IGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQIEA |
| Q15560 | T254 | Sugiyama | TCEA2 | IRKAMTKEAIREHQMARTGGtQTDLFtCGKCRKKNCTYTQV |
| Q15813 | T56 | Sugiyama | TBCE | WLGVEWDNPERGKHDGSHEGtVyFKCRHPTGGSFIRPNKVN |
| Q15813 | Y58 | Sugiyama | TBCE | GVEWDNPERGKHDGSHEGtVyFKCRHPTGGSFIRPNKVNFG |
| Q16181 | T318 | Sugiyama | SEPTIN7 CDC10 SEPT7 | KDVTNNVHyENyRSRKLAAVtyNGVDNNKNKGQLtKsPLAQ |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T291 | Sugiyama | HAGH GLO2 HAGH1 | PFMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD___ |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | S67 | Sugiyama | HSP90AB3P HSP90BC | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERTLALV |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S67 | Sugiyama | HSP90AB2P HSP90BB | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQEHTLTLV |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q5VTE0 | T22 | Sugiyama | EEF1A1P5 EEF1AL3 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7L014 | T885 | Sugiyama | DDX46 KIAA0801 | LGIESQDVMQQATNAILRGGtILAPtVsAKTIAEQLAEKIN |
| Q7L014 | T890 | Sugiyama | DDX46 KIAA0801 | QDVMQQATNAILRGGtILAPtVsAKTIAEQLAEKINAKLNy |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92522 | T55 | Sugiyama | H1-10 H1FX | KRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLAKIYTEAK |
| Q92882 | T200 | Sugiyama | OSTF1 | ATNAACAsLLKKKQGTDAVRtLsNAEDyLDDEDsD______ |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q96C86 | T318 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | LAEVIENLECDPRHyQQRTLtFALRADDPLLKLLQEAQQS_ |
| Q96G46 | T167 | Sugiyama | DUS3L | VGRYLETKPADLGPRCVLFEtFGRCPYGVtCRFAGAHLRPE |
| Q96G46 | T176 | Sugiyama | DUS3L | ADLGPRCVLFEtFGRCPYGVtCRFAGAHLRPEGQNLVQEEL |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99436 | T273 | Sugiyama | PSMB7 Z | AVLTEKITPLEIEVLEEtVQtMDts________________ |
| Q99547 | T124 | Sugiyama | MPHOSPH6 MPP6 | TVELDVsDEEMARRyEtLVGtIGKKFARKRDHANYEEDENG |
| Q99547 | Y118 | Sugiyama | MPHOSPH6 MPP6 | EEVEDETVELDVsDEEMARRyEtLVGtIGKKFARKRDHANY |
| Q99575 | S129 | Sugiyama | POP1 KIAA0061 | QARAAEISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHNVK |
| Q99575 | T134 | Sugiyama | POP1 KIAA0061 | EISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHNVKRLPRR |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99700 | S508 | Sugiyama | ATXN2 ATX2 SCA2 TNRC13 | TRENKYIPPGQRNREVIsWGsGRQNsPRMGQPGsGSMPSRs |
| Q99733 | T24 | Sugiyama | NAP1L4 NAP2 | HsFsDGVPsDsVEAAKNAsNtEKLtDQVMQNPRVLAALQER |
| Q99733 | T28 | Sugiyama | NAP1L4 NAP2 | DGVPsDsVEAAKNAsNtEKLtDQVMQNPRVLAALQERLDNV |
| Q99733 | T58 | Sugiyama | NAP1L4 NAP2 | LAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQVRCA |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BSQ5 | S384 | SIGNOR|EPSD|PSP | CCM2 C7orf22 PP10187 | HFENFLETIGVKDGRGIItDsFGRHRRALstTssStTNGNR |
| Q9BUL8 | S39 | SIGNOR|EPSD|PSP | PDCD10 CCM3 TFAR15 | SMPLYAVMYPVFNELERVNLsAAQtLRAAFIKAEKENPGLT |
| Q9BUL8 | T43 | SIGNOR|EPSD|PSP | PDCD10 CCM3 TFAR15 | YAVMYPVFNELERVNLsAAQtLRAAFIKAEKENPGLTQDII |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H0B6 | S539 | Sugiyama | KLC2 | sEsDLEDVGPTAEWNGDGsGsLRRSGsFGKLRDALRRsSEM |
| Q9H173 | T123 | Sugiyama | SIL1 UNQ545/PRO836 | KLQYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAE |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H2U1 | T179 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NRsyIDRDsEyLLQENEPDGtLDQKLLEDLQKKKNDLRYIE |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NZM1 | T172 | Sugiyama | MYOF FER1L3 KIAA1207 | GDEDRLDNAVRGPGPKGPVGtVsEAQLARRLtKVKNSRRML |
| Q9NZZ3 | T23 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | RLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRLDAELV |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9P258 | T20 | Sugiyama | RCC2 KIAA1470 TD60 | _MPRKKAAAAAWEEPssGNGtARAGPRKRGGPAGRKRERPE |
| Q9P2E9 | T684 | Sugiyama | RRBP1 KIAA1398 | EGEAQRLIEILSEKAGIIQDtWHKATQKGDPVAILKRQLEE |
| Q9P2J5 | T721 | Sugiyama | LARS1 KIAA1352 LARS | PTAVRANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRL |
| Q9P2J5 | T726 | Sugiyama | LARS1 KIAA1352 LARS | ANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRLALADA |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UEG4 | T384 | Sugiyama | ZNF629 KIAA0326 ZNF65 | HQRTHLREDPFKCPVCGKTFtLSAtLLRHQRTHTGERPYKC |
| Q9UEG4 | T388 | Sugiyama | ZNF629 KIAA0326 ZNF65 | HLREDPFKCPVCGKTFtLSAtLLRHQRTHTGERPYKCPECG |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9ULT8 | S248 | Sugiyama | HECTD1 KIAA1131 | AKHGLTEELLSRMAAAGGTVsGPssACKPGRSTTGAPSTTA |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNX3 | T94 | Sugiyama | RPL26L1 RPL26P1 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y285 | S199 | Sugiyama | FARSA FARS FARSL FARSLA | SAFSTsISKQETELsPEMIssGSWRDRPFKPYNFLAHGVLP |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3F4 | T48 | Sugiyama | STRAP MAWD UNRIP | YGYFLISACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLN |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y6E0 | T182 | Sugiyama | STK24 MST3 STK3 | VLLSEHGEVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEV |
| Q9Y6E0 | T184 | Sugiyama | STK24 MST3 STK3 | LSEHGEVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 4.125589e-13 | 12.385 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.750854e-09 | 8.240 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.751220e-08 | 7.323 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.951277e-06 | 5.710 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.354883e-06 | 5.628 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.156990e-06 | 5.381 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.230117e-06 | 5.374 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.934966e-06 | 5.227 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.310452e-06 | 5.200 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.640810e-06 | 5.178 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.086620e-06 | 5.150 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.006733e-06 | 5.045 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.461267e-06 | 5.024 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.173837e-05 | 4.930 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.309859e-05 | 4.883 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.743811e-05 | 4.759 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.994057e-05 | 4.700 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.460019e-05 | 4.609 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.830776e-05 | 4.548 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.899880e-05 | 4.538 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.434612e-05 | 4.464 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.672893e-05 | 4.435 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.977968e-05 | 4.303 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.288624e-05 | 4.201 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.177188e-05 | 4.209 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.356414e-05 | 4.197 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.684287e-05 | 4.175 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.927709e-05 | 4.101 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.567013e-05 | 4.067 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.092361e-05 | 4.041 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.210121e-04 | 3.917 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.191078e-04 | 3.924 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.206989e-04 | 3.918 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.261222e-04 | 3.899 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.843445e-04 | 3.734 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.848651e-04 | 3.733 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.069506e-04 | 3.684 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.032373e-04 | 3.518 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.015173e-04 | 3.521 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.277390e-04 | 3.484 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.870465e-04 | 3.412 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.308840e-04 | 3.366 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.309600e-04 | 3.366 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.879404e-04 | 3.312 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.917124e-04 | 3.308 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.824448e-04 | 3.166 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.502797e-04 | 3.125 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.502797e-04 | 3.125 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.279397e-04 | 3.138 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.807055e-04 | 3.108 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.807055e-04 | 3.108 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.067267e-04 | 3.093 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.482289e-04 | 3.023 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.153929e-04 | 3.038 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.482289e-04 | 3.023 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.808534e-04 | 3.008 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.837442e-04 | 3.007 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.016854e-03 | 2.993 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.016854e-03 | 2.993 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.036211e-03 | 2.985 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.011929e-03 | 2.995 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.088661e-03 | 2.963 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.110198e-03 | 2.955 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.304300e-03 | 2.885 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.281446e-03 | 2.892 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.277555e-03 | 2.894 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.378792e-03 | 2.861 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.390500e-03 | 2.857 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.545179e-03 | 2.811 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.497967e-03 | 2.824 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.623296e-03 | 2.790 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.671680e-03 | 2.777 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.695604e-03 | 2.771 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.844902e-03 | 2.734 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.855956e-03 | 2.731 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.881461e-03 | 2.726 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.973204e-03 | 2.705 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.124601e-03 | 2.673 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.382706e-03 | 2.623 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.632588e-03 | 2.580 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.896478e-03 | 2.538 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.053120e-03 | 2.515 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.061313e-03 | 2.514 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.002760e-03 | 2.522 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.137822e-03 | 2.503 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.128503e-03 | 2.505 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.213848e-03 | 2.493 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.386367e-03 | 2.470 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.955832e-03 | 2.403 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.114392e-03 | 2.386 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.320968e-03 | 2.364 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.560826e-03 | 2.341 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.901296e-03 | 2.310 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.901296e-03 | 2.310 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.956478e-03 | 2.305 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.956478e-03 | 2.305 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.956478e-03 | 2.305 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.956478e-03 | 2.305 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.956478e-03 | 2.305 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.643916e-03 | 2.333 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.956478e-03 | 2.305 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.901296e-03 | 2.310 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.689956e-03 | 2.329 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.185198e-03 | 2.285 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.192744e-03 | 2.285 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.485005e-03 | 2.261 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.320983e-03 | 2.199 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.125275e-03 | 2.213 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.320983e-03 | 2.199 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.645574e-03 | 2.177 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.187282e-03 | 2.143 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.272864e-03 | 2.082 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.372649e-03 | 2.077 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.512790e-03 | 2.070 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.915268e-03 | 2.050 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.939246e-03 | 2.049 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.939246e-03 | 2.049 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.939246e-03 | 2.049 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.001845e-03 | 2.046 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.783572e-03 | 2.010 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.260055e-02 | 1.900 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.260055e-02 | 1.900 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.260055e-02 | 1.900 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.260055e-02 | 1.900 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.260055e-02 | 1.900 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.260055e-02 | 1.900 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.260055e-02 | 1.900 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.161982e-02 | 1.935 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.161982e-02 | 1.935 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.161982e-02 | 1.935 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.250271e-02 | 1.903 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.153470e-02 | 1.938 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.062317e-02 | 1.974 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.062317e-02 | 1.974 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.203976e-02 | 1.919 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.181833e-02 | 1.927 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.161982e-02 | 1.935 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.198340e-02 | 1.921 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.314997e-02 | 1.881 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.458048e-02 | 1.836 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.415153e-02 | 1.849 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.520753e-02 | 1.818 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.404226e-02 | 1.853 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.406039e-02 | 1.852 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.406039e-02 | 1.852 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.545752e-02 | 1.811 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.567610e-02 | 1.805 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.572373e-02 | 1.803 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.575394e-02 | 1.803 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.656073e-02 | 1.781 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.686435e-02 | 1.773 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.686435e-02 | 1.773 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.686435e-02 | 1.773 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.693512e-02 | 1.771 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.694796e-02 | 1.771 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.704447e-02 | 1.768 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.804354e-02 | 1.744 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.832474e-02 | 1.737 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.840864e-02 | 1.735 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.853441e-02 | 1.732 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.915495e-02 | 1.718 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.186031e-02 | 1.660 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.186031e-02 | 1.660 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.186031e-02 | 1.660 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.159091e-02 | 1.666 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.186031e-02 | 1.660 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.186031e-02 | 1.660 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.000643e-02 | 1.699 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.190892e-02 | 1.659 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.200564e-02 | 1.657 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.277151e-02 | 1.643 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.282030e-02 | 1.642 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.297617e-02 | 1.639 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.318491e-02 | 1.635 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.326492e-02 | 1.633 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.389523e-02 | 1.622 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.683850e-02 | 1.571 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.683850e-02 | 1.571 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.683850e-02 | 1.571 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.608299e-02 | 1.584 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.799349e-02 | 1.553 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.799349e-02 | 1.553 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.799349e-02 | 1.553 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.562461e-02 | 1.591 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.465509e-02 | 1.608 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.799349e-02 | 1.553 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.799349e-02 | 1.553 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.813220e-02 | 1.551 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.843758e-02 | 1.546 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.608299e-02 | 1.584 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.608299e-02 | 1.584 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.816134e-02 | 1.550 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.500469e-02 | 1.602 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.740750e-02 | 1.562 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.917123e-02 | 1.535 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.020618e-02 | 1.520 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.053704e-02 | 1.515 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.071042e-02 | 1.513 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.071042e-02 | 1.513 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.083869e-02 | 1.511 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.113340e-02 | 1.507 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.113340e-02 | 1.507 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.122013e-02 | 1.506 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.134085e-02 | 1.504 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.253035e-02 | 1.488 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.253035e-02 | 1.488 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.255180e-02 | 1.487 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 4.111206e-02 | 1.386 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 4.111206e-02 | 1.386 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.111206e-02 | 1.386 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 4.111206e-02 | 1.386 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 4.111206e-02 | 1.386 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 4.111206e-02 | 1.386 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.111206e-02 | 1.386 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 4.111206e-02 | 1.386 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 4.111206e-02 | 1.386 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.111206e-02 | 1.386 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 4.111206e-02 | 1.386 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.111206e-02 | 1.386 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 4.111206e-02 | 1.386 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.573927e-02 | 1.447 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.515618e-02 | 1.454 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.968591e-02 | 1.401 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.650906e-02 | 1.438 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.768704e-02 | 1.424 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.018757e-02 | 1.396 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.934286e-02 | 1.405 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.899746e-02 | 1.409 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.899746e-02 | 1.409 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.656529e-02 | 1.437 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.911764e-02 | 1.408 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.508840e-02 | 1.455 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.508840e-02 | 1.455 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.554754e-02 | 1.449 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.769701e-02 | 1.424 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.116432e-02 | 1.385 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.120973e-02 | 1.385 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.364141e-02 | 1.360 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.364141e-02 | 1.360 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.513364e-02 | 1.345 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.518502e-02 | 1.345 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.518502e-02 | 1.345 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.518502e-02 | 1.345 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.538003e-02 | 1.343 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.538003e-02 | 1.343 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.697861e-02 | 1.328 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.697861e-02 | 1.328 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.715151e-02 | 1.327 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.886274e-02 | 1.311 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.928508e-02 | 1.307 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.190123e-02 | 1.285 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.190123e-02 | 1.285 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.190123e-02 | 1.285 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.240322e-02 | 1.281 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.317371e-02 | 1.274 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.374777e-02 | 1.270 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.374777e-02 | 1.270 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.374777e-02 | 1.270 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.446459e-02 | 1.264 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.566013e-02 | 1.254 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.688791e-02 | 1.175 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.666625e-02 | 1.176 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.666625e-02 | 1.176 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.164494e-02 | 1.210 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.045156e-02 | 1.219 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.766068e-02 | 1.239 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.291318e-02 | 1.201 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.973988e-02 | 1.224 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.688791e-02 | 1.175 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.688791e-02 | 1.175 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.682671e-02 | 1.175 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.164494e-02 | 1.210 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.045156e-02 | 1.219 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.878063e-02 | 1.163 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.566013e-02 | 1.254 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.725217e-02 | 1.172 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.688791e-02 | 1.175 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.844014e-02 | 1.233 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.688791e-02 | 1.175 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.956343e-02 | 1.158 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.956343e-02 | 1.158 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.228289e-02 | 1.141 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.352003e-02 | 1.134 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.394100e-02 | 1.131 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.484718e-02 | 1.126 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.484718e-02 | 1.126 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.484718e-02 | 1.126 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.489662e-02 | 1.126 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.792963e-02 | 1.108 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.878899e-02 | 1.104 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.878899e-02 | 1.104 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.878899e-02 | 1.104 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.878899e-02 | 1.104 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 8.053631e-02 | 1.094 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.053631e-02 | 1.094 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 8.053631e-02 | 1.094 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.053631e-02 | 1.094 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.053631e-02 | 1.094 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.053631e-02 | 1.094 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.155147e-02 | 1.089 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.378991e-02 | 1.077 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.378991e-02 | 1.077 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.378991e-02 | 1.077 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.378991e-02 | 1.077 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.522968e-02 | 1.069 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.575405e-02 | 1.067 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.183420e-01 | 0.927 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 1.183420e-01 | 0.927 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.183420e-01 | 0.927 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 1.183420e-01 | 0.927 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.183420e-01 | 0.927 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.183420e-01 | 0.927 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.183420e-01 | 0.927 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 1.183420e-01 | 0.927 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.183420e-01 | 0.927 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.183420e-01 | 0.927 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.183420e-01 | 0.927 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 1.183420e-01 | 0.927 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.128919e-02 | 1.040 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.043193e-01 | 0.982 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.043193e-01 | 0.982 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.178148e-01 | 0.929 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.178148e-01 | 0.929 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.178148e-01 | 0.929 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.948435e-02 | 1.048 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.772573e-02 | 1.010 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.772573e-02 | 1.010 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.772573e-02 | 1.010 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.062613e-01 | 0.974 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.092762e-01 | 0.961 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 9.128919e-02 | 1.040 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.043193e-01 | 0.982 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 1.161335e-01 | 0.935 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.948435e-02 | 1.048 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.523039e-02 | 1.021 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.613376e-02 | 1.017 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.092762e-01 | 0.961 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.161335e-01 | 0.935 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.009981e-02 | 1.045 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.183420e-01 | 0.927 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.183420e-01 | 0.927 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.128919e-02 | 1.040 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.043193e-01 | 0.982 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.178148e-01 | 0.929 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.109720e-01 | 0.955 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.152468e-01 | 0.938 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.948435e-02 | 1.048 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.069726e-01 | 0.971 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.135689e-01 | 0.945 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.183420e-01 | 0.927 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.128919e-02 | 1.040 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.062613e-01 | 0.974 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.043193e-01 | 0.982 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.230843e-02 | 1.035 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.043193e-01 | 0.982 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.062613e-01 | 0.974 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.161335e-01 | 0.935 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.128919e-02 | 1.040 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.128919e-02 | 1.040 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.062613e-01 | 0.974 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.092762e-01 | 0.961 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.043193e-01 | 0.982 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.083081e-01 | 0.965 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.186015e-01 | 0.926 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.186015e-01 | 0.926 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.186015e-01 | 0.926 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.188789e-01 | 0.925 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.231737e-01 | 0.909 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.235387e-01 | 0.908 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.237434e-01 | 0.907 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.241559e-01 | 0.906 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.241559e-01 | 0.906 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.253121e-01 | 0.902 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.285920e-01 | 0.891 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.303910e-01 | 0.885 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.317155e-01 | 0.880 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.317155e-01 | 0.880 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.317155e-01 | 0.880 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.317155e-01 | 0.880 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.317155e-01 | 0.880 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.317155e-01 | 0.880 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.893601e-01 | 0.723 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.226973e-01 | 0.652 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.226973e-01 | 0.652 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.226973e-01 | 0.652 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.226973e-01 | 0.652 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.226973e-01 | 0.652 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.226973e-01 | 0.652 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.226973e-01 | 0.652 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.226973e-01 | 0.652 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.546655e-01 | 0.594 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.546655e-01 | 0.594 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.546655e-01 | 0.594 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.546655e-01 | 0.594 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.853208e-01 | 0.545 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.853208e-01 | 0.545 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.853208e-01 | 0.545 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.853208e-01 | 0.545 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.605126e-01 | 0.794 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.147170e-01 | 0.502 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.147170e-01 | 0.502 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.147170e-01 | 0.502 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 3.147170e-01 | 0.502 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.903079e-01 | 0.721 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.334850e-01 | 0.875 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.054696e-01 | 0.687 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.429058e-01 | 0.465 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.429058e-01 | 0.465 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.429058e-01 | 0.465 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.429058e-01 | 0.465 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.429058e-01 | 0.465 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.429058e-01 | 0.465 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 3.429058e-01 | 0.465 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 3.429058e-01 | 0.465 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.528308e-01 | 0.816 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.628172e-01 | 0.788 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.628172e-01 | 0.788 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.361277e-01 | 0.627 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.699368e-01 | 0.432 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.699368e-01 | 0.432 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.699368e-01 | 0.432 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.699368e-01 | 0.432 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.699368e-01 | 0.432 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.377788e-01 | 0.861 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.958573e-01 | 0.402 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.958573e-01 | 0.402 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.958573e-01 | 0.402 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.958573e-01 | 0.402 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.530405e-01 | 0.815 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.824557e-01 | 0.549 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.978746e-01 | 0.526 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.371887e-01 | 0.625 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.132403e-01 | 0.504 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.132403e-01 | 0.504 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.132403e-01 | 0.504 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.285312e-01 | 0.483 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.285312e-01 | 0.483 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.567815e-01 | 0.805 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.462537e-01 | 0.609 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.553080e-01 | 0.593 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.556035e-01 | 0.592 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.387732e-01 | 0.470 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.461175e-01 | 0.609 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.530122e-01 | 0.597 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.427987e-01 | 0.615 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.810895e-01 | 0.551 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.882183e-01 | 0.540 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.484034e-01 | 0.458 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.484034e-01 | 0.458 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.981878e-01 | 0.703 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.277962e-01 | 0.484 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.098196e-01 | 0.509 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.766688e-01 | 0.424 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.463601e-01 | 0.460 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.571343e-01 | 0.804 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.832620e-01 | 0.417 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.847357e-01 | 0.733 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.594499e-01 | 0.586 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.833415e-01 | 0.737 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.938497e-01 | 0.713 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.594499e-01 | 0.586 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.149105e-01 | 0.668 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.366147e-01 | 0.626 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.614784e-01 | 0.442 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.688262e-01 | 0.433 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.900546e-01 | 0.721 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.828410e-01 | 0.548 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.278950e-01 | 0.484 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.196369e-01 | 0.495 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.207547e-01 | 0.656 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.764407e-01 | 0.753 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.619330e-01 | 0.791 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.098196e-01 | 0.509 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.257804e-01 | 0.646 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.528308e-01 | 0.816 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.285312e-01 | 0.483 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.870227e-01 | 0.728 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.741436e-01 | 0.759 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.195581e-01 | 0.658 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.069334e-01 | 0.513 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.048459e-01 | 0.516 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.069334e-01 | 0.513 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.459655e-01 | 0.836 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.207547e-01 | 0.656 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.160182e-01 | 0.500 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.652069e-01 | 0.437 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.115023e-01 | 0.507 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.342071e-01 | 0.872 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.853173e-01 | 0.732 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.610971e-01 | 0.442 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.610971e-01 | 0.442 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.553080e-01 | 0.593 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.689051e-01 | 0.772 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.978746e-01 | 0.526 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.226973e-01 | 0.652 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.546655e-01 | 0.594 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.546655e-01 | 0.594 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.459655e-01 | 0.836 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.605126e-01 | 0.794 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.430484e-01 | 0.845 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.609008e-01 | 0.793 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.347327e-01 | 0.871 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.605424e-01 | 0.794 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.605424e-01 | 0.794 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.605424e-01 | 0.794 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.605424e-01 | 0.794 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.685755e-01 | 0.773 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.427987e-01 | 0.615 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.802340e-01 | 0.420 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.207547e-01 | 0.656 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.515554e-01 | 0.599 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.184893e-01 | 0.661 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.184893e-01 | 0.661 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.184893e-01 | 0.661 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.605126e-01 | 0.794 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.347327e-01 | 0.871 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.921197e-01 | 0.534 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.937111e-01 | 0.713 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.226973e-01 | 0.652 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.226973e-01 | 0.652 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.226973e-01 | 0.652 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.853208e-01 | 0.545 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.400956e-01 | 0.620 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.400956e-01 | 0.620 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.882183e-01 | 0.540 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.515554e-01 | 0.599 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.273971e-01 | 0.485 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.482810e-01 | 0.605 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.921197e-01 | 0.534 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.958573e-01 | 0.402 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.132403e-01 | 0.504 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.911861e-01 | 0.536 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.515554e-01 | 0.599 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.410017e-01 | 0.851 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.666259e-01 | 0.778 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.833415e-01 | 0.737 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.223131e-01 | 0.492 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 2.853208e-01 | 0.545 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.853208e-01 | 0.545 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.605126e-01 | 0.794 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.147170e-01 | 0.502 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.334850e-01 | 0.875 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.054696e-01 | 0.687 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.699368e-01 | 0.432 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.594499e-01 | 0.586 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.567815e-01 | 0.805 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.515132e-01 | 0.820 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.588112e-01 | 0.445 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.046466e-01 | 0.516 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.478526e-01 | 0.830 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.885765e-01 | 0.411 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.201677e-01 | 0.495 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.566831e-01 | 0.805 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.605424e-01 | 0.794 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.588112e-01 | 0.445 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.890855e-01 | 0.723 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.552679e-01 | 0.593 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.429058e-01 | 0.465 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.599598e-01 | 0.585 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 3.603777e-01 | 0.443 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.546655e-01 | 0.594 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.699368e-01 | 0.432 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.706829e-01 | 0.568 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.160182e-01 | 0.500 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.160182e-01 | 0.500 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.737658e-01 | 0.427 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.860716e-01 | 0.413 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.652781e-01 | 0.782 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.377788e-01 | 0.861 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.226973e-01 | 0.652 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.429058e-01 | 0.465 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.429058e-01 | 0.465 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.958573e-01 | 0.402 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.958573e-01 | 0.402 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.108387e-01 | 0.676 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.932190e-01 | 0.714 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.160182e-01 | 0.500 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.478181e-01 | 0.606 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.333646e-01 | 0.632 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.523832e-01 | 0.453 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.132403e-01 | 0.504 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.268248e-01 | 0.486 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.271385e-01 | 0.485 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.054696e-01 | 0.687 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.729924e-01 | 0.762 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.372727e-01 | 0.625 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.737658e-01 | 0.427 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.469096e-01 | 0.460 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.455865e-01 | 0.837 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.268248e-01 | 0.486 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.478526e-01 | 0.830 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.702030e-01 | 0.432 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.455865e-01 | 0.837 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.469096e-01 | 0.460 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.685755e-01 | 0.773 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.727895e-01 | 0.429 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.727895e-01 | 0.429 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.609008e-01 | 0.793 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.726654e-01 | 0.763 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.893601e-01 | 0.723 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.226973e-01 | 0.652 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.226973e-01 | 0.652 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.853208e-01 | 0.545 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.147170e-01 | 0.502 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.054696e-01 | 0.687 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.429058e-01 | 0.465 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.429058e-01 | 0.465 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.429058e-01 | 0.465 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.699368e-01 | 0.432 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.699368e-01 | 0.432 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.699368e-01 | 0.432 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.699368e-01 | 0.432 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.958573e-01 | 0.402 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.371887e-01 | 0.625 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.482810e-01 | 0.605 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.553080e-01 | 0.593 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.386264e-01 | 0.622 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.714948e-01 | 0.566 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.414252e-01 | 0.467 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.727895e-01 | 0.429 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.893199e-01 | 0.723 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.530405e-01 | 0.815 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.453661e-01 | 0.838 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.195581e-01 | 0.658 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.609008e-01 | 0.793 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.347327e-01 | 0.871 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.885765e-01 | 0.411 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.893601e-01 | 0.723 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.147170e-01 | 0.502 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.670074e-01 | 0.573 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.958573e-01 | 0.402 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.792691e-01 | 0.746 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.316807e-01 | 0.479 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.278311e-01 | 0.642 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.054696e-01 | 0.687 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.528308e-01 | 0.816 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.746083e-01 | 0.758 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.046466e-01 | 0.516 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.734101e-01 | 0.563 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.770462e-01 | 0.752 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.906255e-01 | 0.720 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.588803e-01 | 0.799 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.952862e-01 | 0.403 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.866488e-01 | 0.729 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.941971e-01 | 0.404 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.226973e-01 | 0.652 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.546655e-01 | 0.594 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.546655e-01 | 0.594 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.459655e-01 | 0.836 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.853208e-01 | 0.545 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.147170e-01 | 0.502 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.054696e-01 | 0.687 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.429058e-01 | 0.465 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.958573e-01 | 0.402 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.958573e-01 | 0.402 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.958573e-01 | 0.402 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.958573e-01 | 0.402 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.958573e-01 | 0.402 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.045027e-01 | 0.689 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.132403e-01 | 0.504 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.437275e-01 | 0.464 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.295668e-01 | 0.482 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.295668e-01 | 0.482 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.461175e-01 | 0.609 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.528308e-01 | 0.816 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.482810e-01 | 0.605 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.010451e-01 | 0.521 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.758694e-01 | 0.425 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.135387e-01 | 0.504 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.903079e-01 | 0.721 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.958573e-01 | 0.402 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.770698e-01 | 0.424 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.661328e-01 | 0.575 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.427987e-01 | 0.615 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.706829e-01 | 0.568 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.578294e-01 | 0.446 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.537228e-01 | 0.451 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.840615e-01 | 0.416 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.589536e-01 | 0.445 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.430484e-01 | 0.845 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 2.515554e-01 | 0.599 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.706829e-01 | 0.568 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.316807e-01 | 0.479 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.853208e-01 | 0.545 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.853208e-01 | 0.545 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.147170e-01 | 0.502 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.429058e-01 | 0.465 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.207547e-01 | 0.656 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.699368e-01 | 0.432 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.958573e-01 | 0.402 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.285312e-01 | 0.483 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.462537e-01 | 0.609 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 3.588112e-01 | 0.445 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.151248e-01 | 0.667 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.267691e-01 | 0.486 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.903079e-01 | 0.721 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.824557e-01 | 0.549 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 2.583027e-01 | 0.588 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.853208e-01 | 0.545 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.958573e-01 | 0.402 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.605424e-01 | 0.794 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.273971e-01 | 0.485 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.758694e-01 | 0.425 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.340732e-01 | 0.476 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.108387e-01 | 0.676 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.605126e-01 | 0.794 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.347327e-01 | 0.871 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.958573e-01 | 0.402 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.277962e-01 | 0.484 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.515554e-01 | 0.599 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.437275e-01 | 0.464 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.515554e-01 | 0.599 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.958573e-01 | 0.402 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.033997e-01 | 0.692 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.430484e-01 | 0.845 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.390118e-01 | 0.470 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.261860e-01 | 0.646 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.437275e-01 | 0.464 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.825736e-01 | 0.739 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.515554e-01 | 0.599 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.820802e-01 | 0.740 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.366262e-01 | 0.626 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.482810e-01 | 0.605 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.125412e-01 | 0.673 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.530122e-01 | 0.597 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.046466e-01 | 0.516 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.389807e-01 | 0.470 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.980468e-01 | 0.400 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.017024e-01 | 0.396 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.032298e-01 | 0.394 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.032298e-01 | 0.394 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.032298e-01 | 0.394 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.032298e-01 | 0.394 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.032298e-01 | 0.394 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.064562e-01 | 0.391 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.091629e-01 | 0.388 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.141520e-01 | 0.383 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.141520e-01 | 0.383 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.141520e-01 | 0.383 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.141520e-01 | 0.383 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.154488e-01 | 0.381 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.158918e-01 | 0.381 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.175641e-01 | 0.379 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.177136e-01 | 0.379 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.177136e-01 | 0.379 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.177136e-01 | 0.379 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.177136e-01 | 0.379 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.201846e-01 | 0.377 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.201846e-01 | 0.377 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.207130e-01 | 0.376 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.207130e-01 | 0.376 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.207130e-01 | 0.376 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.207130e-01 | 0.376 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.207130e-01 | 0.376 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.207130e-01 | 0.376 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.207130e-01 | 0.376 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.207130e-01 | 0.376 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.207130e-01 | 0.376 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.207130e-01 | 0.376 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.207130e-01 | 0.376 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.207130e-01 | 0.376 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.275435e-01 | 0.369 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.276750e-01 | 0.369 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.280096e-01 | 0.369 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.286032e-01 | 0.368 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.320171e-01 | 0.364 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.320171e-01 | 0.364 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.327184e-01 | 0.364 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 4.343805e-01 | 0.362 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.343805e-01 | 0.362 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.348881e-01 | 0.362 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.395668e-01 | 0.357 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.405455e-01 | 0.356 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.419422e-01 | 0.355 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.422162e-01 | 0.354 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.445475e-01 | 0.352 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.445475e-01 | 0.352 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.445475e-01 | 0.352 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.445475e-01 | 0.352 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 4.445475e-01 | 0.352 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 4.445475e-01 | 0.352 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.445475e-01 | 0.352 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.445475e-01 | 0.352 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.445475e-01 | 0.352 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.445475e-01 | 0.352 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.445475e-01 | 0.352 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.461307e-01 | 0.351 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.461307e-01 | 0.351 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 4.461307e-01 | 0.351 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.511209e-01 | 0.346 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.559047e-01 | 0.341 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.592768e-01 | 0.338 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.600457e-01 | 0.337 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.600457e-01 | 0.337 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.602505e-01 | 0.337 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.602505e-01 | 0.337 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.602505e-01 | 0.337 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.609373e-01 | 0.336 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.612439e-01 | 0.336 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.612439e-01 | 0.336 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.612439e-01 | 0.336 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.666570e-01 | 0.331 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 4.674028e-01 | 0.330 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.674028e-01 | 0.330 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.674028e-01 | 0.330 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.674028e-01 | 0.330 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.674028e-01 | 0.330 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.674028e-01 | 0.330 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.674028e-01 | 0.330 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.674028e-01 | 0.330 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.674028e-01 | 0.330 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.674028e-01 | 0.330 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.693273e-01 | 0.329 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.719462e-01 | 0.326 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.719462e-01 | 0.326 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.722312e-01 | 0.326 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.737546e-01 | 0.324 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.737546e-01 | 0.324 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.737546e-01 | 0.324 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.785315e-01 | 0.320 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.815721e-01 | 0.317 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.825872e-01 | 0.316 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.825872e-01 | 0.316 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.825872e-01 | 0.316 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.872508e-01 | 0.312 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.872508e-01 | 0.312 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.872508e-01 | 0.312 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.872508e-01 | 0.312 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.872508e-01 | 0.312 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.872508e-01 | 0.312 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.872508e-01 | 0.312 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.874834e-01 | 0.312 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.893189e-01 | 0.310 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.893189e-01 | 0.310 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.893189e-01 | 0.310 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.893189e-01 | 0.310 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.893189e-01 | 0.310 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.893189e-01 | 0.310 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.893189e-01 | 0.310 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.893189e-01 | 0.310 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.893189e-01 | 0.310 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.893189e-01 | 0.310 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.893189e-01 | 0.310 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.893189e-01 | 0.310 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.893189e-01 | 0.310 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.893189e-01 | 0.310 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.904911e-01 | 0.309 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.930533e-01 | 0.307 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.930533e-01 | 0.307 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.999857e-01 | 0.301 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.005287e-01 | 0.301 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.005287e-01 | 0.301 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.005287e-01 | 0.301 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 5.005287e-01 | 0.301 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.034491e-01 | 0.298 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.034491e-01 | 0.298 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.103345e-01 | 0.292 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.103345e-01 | 0.292 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.103345e-01 | 0.292 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.103345e-01 | 0.292 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.103345e-01 | 0.292 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.103345e-01 | 0.292 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.103345e-01 | 0.292 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.103345e-01 | 0.292 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.103345e-01 | 0.292 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.103345e-01 | 0.292 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.103345e-01 | 0.292 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.103345e-01 | 0.292 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.103345e-01 | 0.292 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.135833e-01 | 0.289 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.135833e-01 | 0.289 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.135833e-01 | 0.289 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.135833e-01 | 0.289 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 5.137341e-01 | 0.289 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.264106e-01 | 0.279 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.264106e-01 | 0.279 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.293041e-01 | 0.276 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.293041e-01 | 0.276 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.304277e-01 | 0.275 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.304865e-01 | 0.275 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.304865e-01 | 0.275 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.304865e-01 | 0.275 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.304865e-01 | 0.275 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.304865e-01 | 0.275 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.304865e-01 | 0.275 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.304865e-01 | 0.275 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.304865e-01 | 0.275 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.304865e-01 | 0.275 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.304865e-01 | 0.275 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.304865e-01 | 0.275 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.304865e-01 | 0.275 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.339572e-01 | 0.272 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.369103e-01 | 0.270 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.390071e-01 | 0.268 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.390071e-01 | 0.268 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.396419e-01 | 0.268 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.463573e-01 | 0.263 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.481004e-01 | 0.261 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.498103e-01 | 0.260 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.498103e-01 | 0.260 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.498103e-01 | 0.260 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.498103e-01 | 0.260 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.498103e-01 | 0.260 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.498103e-01 | 0.260 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.498103e-01 | 0.260 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.498103e-01 | 0.260 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.498103e-01 | 0.260 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.498103e-01 | 0.260 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.498103e-01 | 0.260 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 5.498103e-01 | 0.260 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.498103e-01 | 0.260 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.498103e-01 | 0.260 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.498103e-01 | 0.260 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.513702e-01 | 0.259 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.536964e-01 | 0.257 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.536964e-01 | 0.257 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.633774e-01 | 0.249 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.633774e-01 | 0.249 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.633774e-01 | 0.249 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.634977e-01 | 0.249 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.634977e-01 | 0.249 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.634977e-01 | 0.249 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.634977e-01 | 0.249 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.667502e-01 | 0.247 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.667502e-01 | 0.247 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.683400e-01 | 0.245 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.683400e-01 | 0.245 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.683400e-01 | 0.245 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.683400e-01 | 0.245 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.683400e-01 | 0.245 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.683400e-01 | 0.245 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.683400e-01 | 0.245 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.683400e-01 | 0.245 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.683400e-01 | 0.245 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.683400e-01 | 0.245 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.683400e-01 | 0.245 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.683400e-01 | 0.245 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.683400e-01 | 0.245 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.683400e-01 | 0.245 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.683400e-01 | 0.245 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.683400e-01 | 0.245 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.683400e-01 | 0.245 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.683400e-01 | 0.245 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.713127e-01 | 0.243 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.729296e-01 | 0.242 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.729296e-01 | 0.242 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.740555e-01 | 0.241 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.753880e-01 | 0.240 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.753880e-01 | 0.240 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.753880e-01 | 0.240 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.761973e-01 | 0.239 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.823508e-01 | 0.235 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.823508e-01 | 0.235 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.861080e-01 | 0.232 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.861080e-01 | 0.232 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 5.861080e-01 | 0.232 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 5.861080e-01 | 0.232 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.861080e-01 | 0.232 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 5.861080e-01 | 0.232 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.861080e-01 | 0.232 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.861080e-01 | 0.232 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.861080e-01 | 0.232 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.870401e-01 | 0.231 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 5.870401e-01 | 0.231 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.870401e-01 | 0.231 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.870401e-01 | 0.231 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.870401e-01 | 0.231 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.896004e-01 | 0.229 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.916392e-01 | 0.228 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.984536e-01 | 0.223 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.984536e-01 | 0.223 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.984536e-01 | 0.223 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.015733e-01 | 0.221 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.026141e-01 | 0.220 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.031457e-01 | 0.220 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 6.031457e-01 | 0.220 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.031457e-01 | 0.220 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.031457e-01 | 0.220 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 6.031457e-01 | 0.220 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.031457e-01 | 0.220 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.031457e-01 | 0.220 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.049132e-01 | 0.218 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.095817e-01 | 0.215 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.096282e-01 | 0.215 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.098110e-01 | 0.215 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.105398e-01 | 0.214 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.105398e-01 | 0.214 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.191868e-01 | 0.208 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.194831e-01 | 0.208 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.194831e-01 | 0.208 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.194831e-01 | 0.208 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.194831e-01 | 0.208 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.194831e-01 | 0.208 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.194831e-01 | 0.208 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.194831e-01 | 0.208 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.194831e-01 | 0.208 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.205644e-01 | 0.207 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.205644e-01 | 0.207 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.205644e-01 | 0.207 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.205644e-01 | 0.207 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.233028e-01 | 0.205 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.274345e-01 | 0.202 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.300543e-01 | 0.201 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.302099e-01 | 0.201 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.351488e-01 | 0.197 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.351488e-01 | 0.197 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.351488e-01 | 0.197 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.351488e-01 | 0.197 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.351488e-01 | 0.197 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.351488e-01 | 0.197 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.351488e-01 | 0.197 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.351488e-01 | 0.197 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.351488e-01 | 0.197 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.351488e-01 | 0.197 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 6.351488e-01 | 0.197 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.351488e-01 | 0.197 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.351488e-01 | 0.197 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.351488e-01 | 0.197 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.351488e-01 | 0.197 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.360383e-01 | 0.197 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.417243e-01 | 0.193 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.417243e-01 | 0.193 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.433351e-01 | 0.192 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.445025e-01 | 0.191 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.501705e-01 | 0.187 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.501705e-01 | 0.187 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.501705e-01 | 0.187 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.501705e-01 | 0.187 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.501705e-01 | 0.187 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.501705e-01 | 0.187 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.501705e-01 | 0.187 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 6.501705e-01 | 0.187 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.501705e-01 | 0.187 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.501705e-01 | 0.187 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.501705e-01 | 0.187 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.501705e-01 | 0.187 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.619429e-01 | 0.179 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.619429e-01 | 0.179 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.619429e-01 | 0.179 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.645746e-01 | 0.177 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.645746e-01 | 0.177 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.645746e-01 | 0.177 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 6.645746e-01 | 0.177 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.645746e-01 | 0.177 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.645746e-01 | 0.177 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.645746e-01 | 0.177 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.645746e-01 | 0.177 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.645746e-01 | 0.177 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.645746e-01 | 0.177 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.645746e-01 | 0.177 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.645746e-01 | 0.177 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.645746e-01 | 0.177 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 6.690540e-01 | 0.175 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.717035e-01 | 0.173 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.769569e-01 | 0.169 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.783865e-01 | 0.169 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 6.783865e-01 | 0.169 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.783865e-01 | 0.169 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.783865e-01 | 0.169 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.783865e-01 | 0.169 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.783865e-01 | 0.169 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.812344e-01 | 0.167 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.848527e-01 | 0.164 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.851461e-01 | 0.164 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.905379e-01 | 0.161 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.905379e-01 | 0.161 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.905379e-01 | 0.161 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.915231e-01 | 0.160 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.916304e-01 | 0.160 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.916304e-01 | 0.160 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.916304e-01 | 0.160 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.916304e-01 | 0.160 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.916304e-01 | 0.160 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.916304e-01 | 0.160 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.916304e-01 | 0.160 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.916304e-01 | 0.160 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.916304e-01 | 0.160 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.916304e-01 | 0.160 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 6.916304e-01 | 0.160 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.916304e-01 | 0.160 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.916304e-01 | 0.160 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.980926e-01 | 0.156 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.996167e-01 | 0.155 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.996167e-01 | 0.155 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.998252e-01 | 0.155 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.998252e-01 | 0.155 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.028297e-01 | 0.153 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.043297e-01 | 0.152 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.043297e-01 | 0.152 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.043297e-01 | 0.152 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.043297e-01 | 0.152 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.084734e-01 | 0.150 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.084734e-01 | 0.150 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.134385e-01 | 0.147 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.165068e-01 | 0.145 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.165068e-01 | 0.145 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.165068e-01 | 0.145 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.165068e-01 | 0.145 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.171108e-01 | 0.144 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.171108e-01 | 0.144 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.171108e-01 | 0.144 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.176620e-01 | 0.144 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.214425e-01 | 0.142 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.255322e-01 | 0.139 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.255322e-01 | 0.139 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.281831e-01 | 0.138 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.281831e-01 | 0.138 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.281831e-01 | 0.138 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.281831e-01 | 0.138 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.281831e-01 | 0.138 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.281831e-01 | 0.138 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.281831e-01 | 0.138 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.281831e-01 | 0.138 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.281831e-01 | 0.138 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.281831e-01 | 0.138 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.281831e-01 | 0.138 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.337405e-01 | 0.134 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.337405e-01 | 0.134 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.393792e-01 | 0.131 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.393792e-01 | 0.131 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.393792e-01 | 0.131 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.393792e-01 | 0.131 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.417391e-01 | 0.130 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.495312e-01 | 0.125 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.501147e-01 | 0.125 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.501147e-01 | 0.125 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.501147e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.501147e-01 | 0.125 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.501147e-01 | 0.125 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.501147e-01 | 0.125 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.501147e-01 | 0.125 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.501147e-01 | 0.125 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.501147e-01 | 0.125 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.501147e-01 | 0.125 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.547486e-01 | 0.122 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.547486e-01 | 0.122 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.550835e-01 | 0.122 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.571204e-01 | 0.121 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.604087e-01 | 0.119 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.604087e-01 | 0.119 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.604087e-01 | 0.119 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.604087e-01 | 0.119 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.604087e-01 | 0.119 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.645100e-01 | 0.117 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.645100e-01 | 0.117 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.689099e-01 | 0.114 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.696170e-01 | 0.114 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.702792e-01 | 0.113 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.702792e-01 | 0.113 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.702792e-01 | 0.113 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.702792e-01 | 0.113 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.702792e-01 | 0.113 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.702792e-01 | 0.113 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.717037e-01 | 0.113 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.717037e-01 | 0.113 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.717037e-01 | 0.113 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.740442e-01 | 0.111 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.751169e-01 | 0.111 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.787050e-01 | 0.109 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 7.787050e-01 | 0.109 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.797436e-01 | 0.108 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.797436e-01 | 0.108 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.797436e-01 | 0.108 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.797436e-01 | 0.108 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.797436e-01 | 0.108 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.797436e-01 | 0.108 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.797436e-01 | 0.108 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.797436e-01 | 0.108 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 7.797436e-01 | 0.108 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.847736e-01 | 0.105 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.855176e-01 | 0.105 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.855176e-01 | 0.105 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.855176e-01 | 0.105 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.855176e-01 | 0.105 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.888187e-01 | 0.103 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.888187e-01 | 0.103 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.888187e-01 | 0.103 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.888187e-01 | 0.103 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.888187e-01 | 0.103 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.888187e-01 | 0.103 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.888187e-01 | 0.103 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.893858e-01 | 0.103 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.896695e-01 | 0.103 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.921452e-01 | 0.101 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.921452e-01 | 0.101 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.921860e-01 | 0.101 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 7.975203e-01 | 0.098 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.975203e-01 | 0.098 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.975203e-01 | 0.098 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.012858e-01 | 0.096 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.058640e-01 | 0.094 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.058640e-01 | 0.094 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.058640e-01 | 0.094 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.058640e-01 | 0.094 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.058640e-01 | 0.094 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.058640e-01 | 0.094 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.058640e-01 | 0.094 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.058640e-01 | 0.094 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.116937e-01 | 0.091 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.138643e-01 | 0.089 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.138643e-01 | 0.089 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.138643e-01 | 0.089 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 8.138643e-01 | 0.089 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.138643e-01 | 0.089 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.138643e-01 | 0.089 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 8.215354e-01 | 0.085 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.215354e-01 | 0.085 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.215354e-01 | 0.085 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.215354e-01 | 0.085 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.215354e-01 | 0.085 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.215354e-01 | 0.085 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.215354e-01 | 0.085 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.215354e-01 | 0.085 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.215354e-01 | 0.085 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.215354e-01 | 0.085 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.215354e-01 | 0.085 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.215354e-01 | 0.085 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.259015e-01 | 0.083 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.288908e-01 | 0.082 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.288908e-01 | 0.082 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.288908e-01 | 0.082 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.311296e-01 | 0.080 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.311296e-01 | 0.080 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.359434e-01 | 0.078 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.359434e-01 | 0.078 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.359434e-01 | 0.078 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.359434e-01 | 0.078 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.359762e-01 | 0.078 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.427058e-01 | 0.074 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.427058e-01 | 0.074 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.427058e-01 | 0.074 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.427058e-01 | 0.074 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.438949e-01 | 0.074 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 8.440718e-01 | 0.074 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.441110e-01 | 0.074 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 8.490505e-01 | 0.071 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.490505e-01 | 0.071 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.490505e-01 | 0.071 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.491898e-01 | 0.071 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.491898e-01 | 0.071 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.491898e-01 | 0.071 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.491898e-01 | 0.071 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.491898e-01 | 0.071 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.491898e-01 | 0.071 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.538842e-01 | 0.069 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.538842e-01 | 0.069 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.538842e-01 | 0.069 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.554070e-01 | 0.068 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.554070e-01 | 0.068 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.554070e-01 | 0.068 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.554070e-01 | 0.068 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.613682e-01 | 0.065 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.613682e-01 | 0.065 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.613682e-01 | 0.065 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.613682e-01 | 0.065 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.613682e-01 | 0.065 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.613682e-01 | 0.065 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.613682e-01 | 0.065 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.631303e-01 | 0.064 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 8.631303e-01 | 0.064 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.642058e-01 | 0.063 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.665556e-01 | 0.062 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.670652e-01 | 0.062 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.670839e-01 | 0.062 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.670839e-01 | 0.062 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.670839e-01 | 0.062 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.680007e-01 | 0.061 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.718376e-01 | 0.060 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.725644e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.725644e-01 | 0.059 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.725644e-01 | 0.059 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.734267e-01 | 0.059 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.778192e-01 | 0.057 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.778192e-01 | 0.057 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.778192e-01 | 0.057 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.778192e-01 | 0.057 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.778192e-01 | 0.057 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.800327e-01 | 0.056 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.828576e-01 | 0.054 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.828576e-01 | 0.054 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.828576e-01 | 0.054 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.839464e-01 | 0.054 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.876886e-01 | 0.052 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.876886e-01 | 0.052 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 8.876886e-01 | 0.052 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.886822e-01 | 0.051 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.917865e-01 | 0.050 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.923206e-01 | 0.049 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.923206e-01 | 0.049 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.923206e-01 | 0.049 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.923206e-01 | 0.049 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.923206e-01 | 0.049 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.923206e-01 | 0.049 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 8.923206e-01 | 0.049 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.923206e-01 | 0.049 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.923206e-01 | 0.049 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.923206e-01 | 0.049 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.923206e-01 | 0.049 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.923206e-01 | 0.049 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.949892e-01 | 0.048 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.967618e-01 | 0.047 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.967618e-01 | 0.047 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.967618e-01 | 0.047 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.984476e-01 | 0.047 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.003563e-01 | 0.046 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.010201e-01 | 0.045 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.010201e-01 | 0.045 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.010201e-01 | 0.045 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.010201e-01 | 0.045 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.051030e-01 | 0.043 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.090178e-01 | 0.041 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.124643e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.127712e-01 | 0.040 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.163701e-01 | 0.038 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.170641e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.175065e-01 | 0.037 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.198207e-01 | 0.036 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.198207e-01 | 0.036 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.198367e-01 | 0.036 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.198367e-01 | 0.036 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.198653e-01 | 0.036 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.222827e-01 | 0.035 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.222827e-01 | 0.035 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.231291e-01 | 0.035 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.233431e-01 | 0.035 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.263012e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.276404e-01 | 0.033 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.276404e-01 | 0.033 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.289742e-01 | 0.032 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.293425e-01 | 0.032 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.293425e-01 | 0.032 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.322586e-01 | 0.030 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.322586e-01 | 0.030 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.324384e-01 | 0.030 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.350545e-01 | 0.029 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.356080e-01 | 0.029 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.377351e-01 | 0.028 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.390746e-01 | 0.027 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.403052e-01 | 0.027 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.403052e-01 | 0.027 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.403052e-01 | 0.027 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.403052e-01 | 0.027 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.427695e-01 | 0.026 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.431500e-01 | 0.025 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.451321e-01 | 0.025 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.451321e-01 | 0.025 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.473973e-01 | 0.023 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.476357e-01 | 0.023 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.484265e-01 | 0.023 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.495692e-01 | 0.022 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.516515e-01 | 0.022 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.551523e-01 | 0.020 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.555621e-01 | 0.020 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.559376e-01 | 0.020 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.559376e-01 | 0.020 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.565591e-01 | 0.019 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.570010e-01 | 0.019 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.573973e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.573973e-01 | 0.019 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.591568e-01 | 0.018 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.599222e-01 | 0.018 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.624611e-01 | 0.017 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.639501e-01 | 0.016 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.640117e-01 | 0.016 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.640117e-01 | 0.016 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.640117e-01 | 0.016 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.654984e-01 | 0.015 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.662011e-01 | 0.015 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.664162e-01 | 0.015 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.664162e-01 | 0.015 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.672267e-01 | 0.014 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.682904e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.682904e-01 | 0.014 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.696005e-01 | 0.013 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.718921e-01 | 0.012 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.720610e-01 | 0.012 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.720829e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.732156e-01 | 0.012 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.732156e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.732156e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.738181e-01 | 0.012 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.738321e-01 | 0.012 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.743225e-01 | 0.011 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.754137e-01 | 0.011 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.764012e-01 | 0.010 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.783119e-01 | 0.010 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.792085e-01 | 0.009 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.817464e-01 | 0.008 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.827348e-01 | 0.008 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.831659e-01 | 0.007 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.836288e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.839257e-01 | 0.007 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.853417e-01 | 0.006 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.869348e-01 | 0.006 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.872457e-01 | 0.006 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.872457e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.899368e-01 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.899872e-01 | 0.004 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.907923e-01 | 0.004 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.908889e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.911552e-01 | 0.004 | 0 | 0 |
| Translation | R-HSA-72766 | 9.913018e-01 | 0.004 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.914381e-01 | 0.004 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.932246e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.934897e-01 | 0.003 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.937101e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.943907e-01 | 0.002 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.947797e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.954602e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.960147e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.966243e-01 | 0.001 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.968984e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.971502e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.975101e-01 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.977192e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.979693e-01 | 0.001 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.980623e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.981840e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.983171e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.986389e-01 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.989694e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.990532e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996991e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.997908e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.998336e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.998676e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.998807e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.998955e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999626e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999745e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999967e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.220446e-16 | 15.654 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.220446e-16 | 15.654 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.110223e-15 | 14.955 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.221245e-15 | 14.913 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.443290e-15 | 14.841 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.665335e-15 | 14.778 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.887379e-15 | 14.724 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.331468e-15 | 14.632 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.775558e-15 | 14.557 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.886580e-15 | 14.540 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.329870e-15 | 14.364 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.769963e-15 | 14.010 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.465494e-14 | 13.834 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.486900e-14 | 13.604 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.352074e-14 | 13.361 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.439294e-14 | 13.191 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.493206e-14 | 13.071 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.200151e-13 | 12.921 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.709743e-13 | 12.767 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.709743e-13 | 12.767 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.769696e-13 | 12.752 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.671996e-13 | 12.777 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.734168e-13 | 12.761 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.171596e-13 | 12.663 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.924638e-13 | 12.406 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.161116e-13 | 12.381 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.649925e-13 | 12.248 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.885292e-13 | 12.230 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.889733e-13 | 12.230 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.797407e-13 | 12.056 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.644196e-13 | 12.063 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.583134e-13 | 12.066 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.110490e-13 | 12.040 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.050937e-12 | 11.978 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.139200e-12 | 11.943 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.323608e-12 | 11.878 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.429967e-12 | 11.845 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.886380e-12 | 11.724 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.873057e-12 | 11.727 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.392286e-12 | 11.470 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.817502e-12 | 11.418 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.772871e-12 | 11.423 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.365397e-12 | 11.360 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.637601e-12 | 11.249 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.701417e-12 | 11.174 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.809553e-12 | 11.167 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.160017e-11 | 10.936 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.602163e-11 | 10.795 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.758760e-11 | 10.559 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.698819e-11 | 10.569 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.192124e-11 | 10.378 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.144940e-11 | 10.382 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.248468e-11 | 10.372 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.762613e-11 | 10.322 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.251055e-11 | 10.280 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.005507e-11 | 10.155 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.856160e-11 | 10.105 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.266703e-10 | 9.897 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.319250e-10 | 9.880 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.752238e-10 | 9.756 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.076281e-10 | 9.683 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.371743e-10 | 9.625 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.454005e-10 | 9.610 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.960626e-10 | 9.529 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.743770e-10 | 9.427 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.154668e-10 | 9.381 | 0 | 0 |
| Translation | R-HSA-72766 | 4.749241e-10 | 9.323 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.103524e-10 | 9.214 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.278631e-10 | 9.202 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.525169e-10 | 9.185 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.045056e-09 | 8.981 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.003805e-09 | 8.998 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.142538e-09 | 8.942 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.284740e-09 | 8.891 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.773346e-09 | 8.751 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.773346e-09 | 8.751 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.773346e-09 | 8.751 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.773346e-09 | 8.751 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.773346e-09 | 8.751 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.950123e-09 | 8.710 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.950123e-09 | 8.710 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.003639e-09 | 8.698 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.152124e-09 | 8.667 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.161934e-09 | 8.665 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.290881e-09 | 8.640 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.654735e-09 | 8.576 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.723199e-09 | 8.565 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.982028e-09 | 8.525 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.150636e-09 | 8.502 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.698076e-09 | 8.432 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.763700e-09 | 8.424 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.823477e-09 | 8.317 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.563501e-09 | 8.255 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.593222e-09 | 8.181 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.529376e-09 | 8.021 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.198007e-08 | 7.922 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.317411e-08 | 7.880 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.565367e-08 | 7.805 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.592596e-08 | 7.798 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.592596e-08 | 7.798 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.743421e-08 | 7.759 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.280199e-08 | 7.642 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.831080e-08 | 7.417 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.027549e-08 | 7.220 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.652625e-08 | 7.248 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.233807e-08 | 7.205 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.742457e-08 | 7.171 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.447954e-08 | 7.128 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.671012e-08 | 7.115 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.787677e-08 | 7.056 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.097642e-08 | 7.041 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.097941e-07 | 6.959 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.082393e-07 | 6.966 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.142625e-07 | 6.942 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.238399e-07 | 6.907 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.293134e-07 | 6.888 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.329990e-07 | 6.876 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.396864e-07 | 6.855 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.438186e-07 | 6.842 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.580833e-07 | 6.801 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.580833e-07 | 6.801 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.825101e-07 | 6.739 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.028867e-07 | 6.693 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.540477e-07 | 6.451 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.603236e-07 | 6.443 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.435012e-07 | 6.353 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.625958e-07 | 6.335 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.980324e-07 | 6.303 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.148280e-07 | 6.288 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.679768e-07 | 6.246 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.746271e-07 | 6.171 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.257118e-07 | 6.139 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.860217e-07 | 6.105 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.555753e-07 | 6.122 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.209501e-07 | 6.086 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.716801e-07 | 6.060 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.005685e-06 | 5.998 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.103817e-06 | 5.957 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.118478e-06 | 5.951 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.137393e-06 | 5.944 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.348296e-06 | 5.870 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.349211e-06 | 5.870 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.371786e-06 | 5.863 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.373994e-06 | 5.862 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.491367e-06 | 5.826 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.496939e-06 | 5.825 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.824693e-06 | 5.739 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.824693e-06 | 5.739 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.240710e-06 | 5.650 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.463065e-06 | 5.609 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.758050e-06 | 5.559 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.030632e-06 | 5.518 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.425248e-06 | 5.465 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.438376e-06 | 5.464 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.598999e-06 | 5.444 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.391399e-06 | 5.357 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.115107e-06 | 5.291 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.173074e-06 | 5.286 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.173074e-06 | 5.286 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.193655e-06 | 5.285 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.372192e-06 | 5.270 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.525007e-06 | 5.258 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.609093e-06 | 5.119 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.522959e-06 | 5.021 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.522959e-06 | 5.021 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.651794e-06 | 5.063 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.638770e-06 | 5.064 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.444840e-06 | 5.025 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.637099e-06 | 5.016 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.020238e-05 | 4.991 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.049313e-05 | 4.979 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.105935e-05 | 4.956 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.123728e-05 | 4.949 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.201176e-05 | 4.920 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.268614e-05 | 4.897 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.425919e-05 | 4.846 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.723105e-05 | 4.764 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.723105e-05 | 4.764 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.723105e-05 | 4.764 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.914753e-05 | 4.718 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.996454e-05 | 4.700 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.996454e-05 | 4.700 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.249613e-05 | 4.648 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.380097e-05 | 4.623 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.641066e-05 | 4.578 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.729921e-05 | 4.564 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.008640e-05 | 4.522 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.236250e-05 | 4.490 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.533665e-05 | 4.452 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.904481e-05 | 4.408 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.916256e-05 | 4.407 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.934215e-05 | 4.405 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.947700e-05 | 4.404 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.292277e-05 | 4.367 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.357030e-05 | 4.361 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.375515e-05 | 4.359 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.413130e-05 | 4.355 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.861974e-05 | 4.313 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.972467e-05 | 4.303 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.144683e-05 | 4.289 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.144683e-05 | 4.289 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.144683e-05 | 4.289 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.247075e-05 | 4.280 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.282387e-05 | 4.202 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.410337e-05 | 4.193 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.717752e-05 | 4.173 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.776798e-05 | 4.169 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.063698e-05 | 4.151 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.417539e-05 | 4.130 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.490584e-05 | 4.125 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.573598e-05 | 4.121 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.270231e-05 | 4.082 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.159441e-05 | 4.038 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.062509e-04 | 3.974 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.191386e-04 | 3.924 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.184026e-04 | 3.927 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.197649e-04 | 3.922 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.062509e-04 | 3.974 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.208857e-04 | 3.918 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.233431e-04 | 3.909 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.233431e-04 | 3.909 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.233431e-04 | 3.909 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.258137e-04 | 3.900 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.382200e-04 | 3.859 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.491366e-04 | 3.826 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.518165e-04 | 3.819 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.522949e-04 | 3.817 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.522949e-04 | 3.817 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.582369e-04 | 3.801 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.582369e-04 | 3.801 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.582369e-04 | 3.801 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.587428e-04 | 3.799 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.734228e-04 | 3.761 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.807831e-04 | 3.743 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.818189e-04 | 3.740 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.840704e-04 | 3.735 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.946503e-04 | 3.711 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.963469e-04 | 3.707 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.060662e-04 | 3.686 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.374231e-04 | 3.624 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.374231e-04 | 3.624 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.160137e-04 | 3.666 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.290541e-04 | 3.640 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.404536e-04 | 3.619 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.080664e-04 | 3.682 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.079877e-04 | 3.682 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.160137e-04 | 3.666 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.247480e-04 | 3.648 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.543961e-04 | 3.594 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.700130e-04 | 3.569 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.701739e-04 | 3.568 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.964466e-04 | 3.528 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.998946e-04 | 3.523 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.101959e-04 | 3.508 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.194170e-04 | 3.496 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.208559e-04 | 3.494 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.208559e-04 | 3.494 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.467381e-04 | 3.460 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.482956e-04 | 3.458 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.536097e-04 | 3.451 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 3.703234e-04 | 3.431 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 3.703234e-04 | 3.431 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.868326e-04 | 3.412 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.888014e-04 | 3.410 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.919079e-04 | 3.407 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.009659e-04 | 3.397 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.340203e-04 | 3.362 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.342846e-04 | 3.362 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.381164e-04 | 3.358 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.381164e-04 | 3.358 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.381164e-04 | 3.358 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.414447e-04 | 3.355 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.787644e-04 | 3.320 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.787644e-04 | 3.320 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.822735e-04 | 3.317 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.822735e-04 | 3.317 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.986615e-04 | 3.302 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.031651e-04 | 3.298 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.414141e-04 | 3.266 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.561938e-04 | 3.255 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.595332e-04 | 3.252 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.850751e-04 | 3.233 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.850751e-04 | 3.233 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.873605e-04 | 3.231 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.883018e-04 | 3.230 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.883018e-04 | 3.230 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.293766e-04 | 3.201 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.683952e-04 | 3.175 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.683952e-04 | 3.175 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.015687e-04 | 3.154 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.179818e-04 | 3.144 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.179818e-04 | 3.144 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.476487e-04 | 3.072 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.531266e-04 | 3.069 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.531266e-04 | 3.069 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.530242e-04 | 3.123 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 7.440625e-04 | 3.128 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.415843e-04 | 3.130 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.171038e-04 | 3.038 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.333934e-04 | 3.079 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.737628e-04 | 3.111 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.746594e-04 | 3.011 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.746594e-04 | 3.011 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.746594e-04 | 3.011 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.746594e-04 | 3.011 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.750749e-04 | 3.011 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.750749e-04 | 3.011 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.750749e-04 | 3.011 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.862274e-04 | 3.006 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.905462e-04 | 3.004 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.905462e-04 | 3.004 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.905462e-04 | 3.004 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.023164e-03 | 2.990 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.066620e-03 | 2.972 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.120182e-03 | 2.951 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.190716e-03 | 2.924 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.190716e-03 | 2.924 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.201749e-03 | 2.920 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.201749e-03 | 2.920 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.249991e-03 | 2.903 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.249991e-03 | 2.903 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.249991e-03 | 2.903 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.249991e-03 | 2.903 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.256770e-03 | 2.901 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.259197e-03 | 2.900 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.284459e-03 | 2.891 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.303114e-03 | 2.885 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.394734e-03 | 2.856 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.424338e-03 | 2.846 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.424338e-03 | 2.846 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.516307e-03 | 2.819 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.516307e-03 | 2.819 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.550995e-03 | 2.809 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.562532e-03 | 2.806 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.682523e-03 | 2.774 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.682523e-03 | 2.774 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.682523e-03 | 2.774 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.696395e-03 | 2.770 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.713635e-03 | 2.766 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.713635e-03 | 2.766 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.740960e-03 | 2.759 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.806016e-03 | 2.743 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.806016e-03 | 2.743 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.858165e-03 | 2.731 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.877979e-03 | 2.726 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.877979e-03 | 2.726 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.928995e-03 | 2.715 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.928995e-03 | 2.715 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.955175e-03 | 2.709 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.979745e-03 | 2.703 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.990635e-03 | 2.701 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.990635e-03 | 2.701 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.354613e-03 | 2.628 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.354613e-03 | 2.628 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.691361e-03 | 2.570 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.691361e-03 | 2.570 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.322224e-03 | 2.634 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.667214e-03 | 2.574 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.572391e-03 | 2.590 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.198526e-03 | 2.658 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.151297e-03 | 2.667 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.267156e-03 | 2.645 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.572391e-03 | 2.590 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.572391e-03 | 2.590 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.077565e-03 | 2.682 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.572391e-03 | 2.590 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.354613e-03 | 2.628 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.691361e-03 | 2.570 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.691361e-03 | 2.570 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.198526e-03 | 2.658 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.667214e-03 | 2.574 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.267156e-03 | 2.645 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.206698e-03 | 2.656 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.198526e-03 | 2.658 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.322224e-03 | 2.634 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.844675e-03 | 2.546 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.901022e-03 | 2.537 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.111758e-03 | 2.507 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.276704e-03 | 2.485 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.276704e-03 | 2.485 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.327681e-03 | 2.478 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.404498e-03 | 2.468 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.404498e-03 | 2.468 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.417637e-03 | 2.466 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.430386e-03 | 2.465 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.450911e-03 | 2.462 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.450911e-03 | 2.462 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.579295e-03 | 2.446 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.579295e-03 | 2.446 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.581505e-03 | 2.446 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.655273e-03 | 2.437 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.679729e-03 | 2.434 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.679729e-03 | 2.434 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.783918e-03 | 2.422 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.811771e-03 | 2.419 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.004786e-03 | 2.397 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.004786e-03 | 2.397 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.039395e-03 | 2.394 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.119350e-03 | 2.385 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.406227e-03 | 2.356 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.583150e-03 | 2.339 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.583150e-03 | 2.339 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.583150e-03 | 2.339 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.583150e-03 | 2.339 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.583150e-03 | 2.339 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.583150e-03 | 2.339 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.597617e-03 | 2.337 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.597617e-03 | 2.337 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.597617e-03 | 2.337 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.597617e-03 | 2.337 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.606996e-03 | 2.337 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.606996e-03 | 2.337 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.606996e-03 | 2.337 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.668235e-03 | 2.331 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.668235e-03 | 2.331 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.754651e-03 | 2.323 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.754651e-03 | 2.323 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.295907e-03 | 2.276 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.407456e-03 | 2.267 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.416371e-03 | 2.266 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.555495e-03 | 2.255 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.555495e-03 | 2.255 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.589508e-03 | 2.253 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.978764e-03 | 2.156 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 8.472702e-03 | 2.072 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 8.472702e-03 | 2.072 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.472702e-03 | 2.072 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.283468e-03 | 2.082 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.283468e-03 | 2.082 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.549387e-03 | 2.122 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.693667e-03 | 2.174 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.285080e-03 | 2.202 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.008530e-03 | 2.096 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.283468e-03 | 2.082 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.733359e-03 | 2.172 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.657570e-03 | 2.247 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.198934e-03 | 2.143 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.881421e-03 | 2.231 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.978764e-03 | 2.156 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.434409e-03 | 2.074 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.678388e-03 | 2.246 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.888037e-03 | 2.162 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.067837e-03 | 2.217 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.067837e-03 | 2.217 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.678388e-03 | 2.246 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.283468e-03 | 2.082 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.231905e-03 | 2.084 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.983237e-03 | 2.223 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.657570e-03 | 2.247 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.549387e-03 | 2.122 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.983237e-03 | 2.223 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.888037e-03 | 2.162 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.364998e-03 | 2.196 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.733359e-03 | 2.172 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.549387e-03 | 2.122 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.549387e-03 | 2.122 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.283468e-03 | 2.082 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.285080e-03 | 2.202 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.285080e-03 | 2.202 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.395662e-03 | 2.076 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.983237e-03 | 2.223 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.678388e-03 | 2.246 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.434426e-03 | 2.129 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.888037e-03 | 2.162 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.938784e-03 | 2.159 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.938784e-03 | 2.159 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.191108e-03 | 2.143 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.285080e-03 | 2.202 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.091378e-03 | 2.092 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.023081e-03 | 2.220 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.710465e-03 | 2.173 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.796704e-03 | 2.168 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.549387e-03 | 2.122 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.517800e-03 | 2.070 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.522469e-03 | 2.069 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.203044e-03 | 2.036 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.230259e-03 | 2.035 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.274015e-03 | 2.033 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.391474e-03 | 2.027 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.391474e-03 | 2.027 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.852160e-03 | 2.006 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.852160e-03 | 2.006 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.986221e-03 | 2.001 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.006584e-02 | 1.997 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.006584e-02 | 1.997 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.006584e-02 | 1.997 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.017805e-02 | 1.992 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.042358e-02 | 1.982 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.042358e-02 | 1.982 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.042358e-02 | 1.982 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.094409e-02 | 1.961 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.094409e-02 | 1.961 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.094409e-02 | 1.961 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.094409e-02 | 1.961 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.094409e-02 | 1.961 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.101953e-02 | 1.958 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.125389e-02 | 1.949 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.153368e-02 | 1.938 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.153368e-02 | 1.938 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.160176e-02 | 1.935 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.160176e-02 | 1.935 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.160176e-02 | 1.935 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.160176e-02 | 1.935 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.163475e-02 | 1.934 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.184185e-02 | 1.927 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.196594e-02 | 1.922 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.207670e-02 | 1.918 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.207670e-02 | 1.918 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.207670e-02 | 1.918 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.207670e-02 | 1.918 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.207670e-02 | 1.918 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.207670e-02 | 1.918 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.208184e-02 | 1.918 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.243757e-02 | 1.905 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.272464e-02 | 1.895 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.277318e-02 | 1.894 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.280616e-02 | 1.893 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.300730e-02 | 1.886 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.300730e-02 | 1.886 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.300730e-02 | 1.886 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.321752e-02 | 1.879 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.347548e-02 | 1.870 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.349414e-02 | 1.870 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.349414e-02 | 1.870 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.353923e-02 | 1.868 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.353923e-02 | 1.868 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.353923e-02 | 1.868 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.357847e-02 | 1.867 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.378966e-02 | 1.860 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.397430e-02 | 1.855 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.399928e-02 | 1.854 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.399928e-02 | 1.854 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.411222e-02 | 1.850 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.411222e-02 | 1.850 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.447166e-02 | 1.839 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.455338e-02 | 1.837 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.455338e-02 | 1.837 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.455338e-02 | 1.837 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.492994e-02 | 1.826 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.514040e-02 | 1.820 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.528263e-02 | 1.816 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.536032e-02 | 1.814 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.536032e-02 | 1.814 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.536032e-02 | 1.814 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.563373e-02 | 1.806 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.567087e-02 | 1.805 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.577804e-02 | 1.802 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.584244e-02 | 1.800 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.584244e-02 | 1.800 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.595110e-02 | 1.797 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.606904e-02 | 1.794 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.615892e-02 | 1.792 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.615892e-02 | 1.792 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.615892e-02 | 1.792 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.652046e-02 | 1.782 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.652046e-02 | 1.782 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.652046e-02 | 1.782 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.662296e-02 | 1.779 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.662296e-02 | 1.779 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.662296e-02 | 1.779 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.701676e-02 | 1.769 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.701676e-02 | 1.769 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.713232e-02 | 1.766 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.741964e-02 | 1.759 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.778095e-02 | 1.750 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.782757e-02 | 1.749 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.782757e-02 | 1.749 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.782757e-02 | 1.749 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.782757e-02 | 1.749 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.800226e-02 | 1.745 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.835203e-02 | 1.736 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.835203e-02 | 1.736 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.835203e-02 | 1.736 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.835203e-02 | 1.736 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.835203e-02 | 1.736 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.836966e-02 | 1.736 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.848464e-02 | 1.733 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.848464e-02 | 1.733 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.899570e-02 | 1.721 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.907120e-02 | 1.720 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.933558e-02 | 1.714 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.026858e-02 | 1.693 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.026858e-02 | 1.693 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.053831e-02 | 1.687 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.129670e-02 | 1.672 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.235120e-02 | 1.651 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.293982e-02 | 1.639 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.328320e-02 | 1.633 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.328320e-02 | 1.633 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.328320e-02 | 1.633 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.328320e-02 | 1.633 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.353029e-02 | 1.628 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.353029e-02 | 1.628 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.355024e-02 | 1.628 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.355024e-02 | 1.628 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.355024e-02 | 1.628 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.357049e-02 | 1.628 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.357049e-02 | 1.628 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.359567e-02 | 1.627 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.359567e-02 | 1.627 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.475366e-02 | 1.606 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.484480e-02 | 1.605 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.546427e-02 | 1.594 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.548144e-02 | 1.594 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.548144e-02 | 1.594 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.548144e-02 | 1.594 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.548144e-02 | 1.594 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.575357e-02 | 1.589 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.575357e-02 | 1.589 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.575357e-02 | 1.589 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.624046e-02 | 1.581 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.624046e-02 | 1.581 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.624046e-02 | 1.581 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.680424e-02 | 1.572 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.711817e-02 | 1.567 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.711817e-02 | 1.567 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.733648e-02 | 1.563 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.733648e-02 | 1.563 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.751528e-02 | 1.560 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.755060e-02 | 1.560 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.836177e-02 | 1.547 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.836177e-02 | 1.547 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.836177e-02 | 1.547 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.869752e-02 | 1.542 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.901971e-02 | 1.537 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.901971e-02 | 1.537 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.906337e-02 | 1.537 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.912514e-02 | 1.536 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.941291e-02 | 1.531 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.941291e-02 | 1.531 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.097218e-02 | 1.509 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.097218e-02 | 1.509 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.098555e-02 | 1.509 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.138313e-02 | 1.503 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.138313e-02 | 1.503 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.138313e-02 | 1.503 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.189809e-02 | 1.496 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.021841e-02 | 1.396 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.413078e-02 | 1.467 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.413078e-02 | 1.467 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.350443e-02 | 1.272 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.350443e-02 | 1.272 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.350443e-02 | 1.272 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.447814e-02 | 1.352 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.037559e-02 | 1.298 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.037559e-02 | 1.298 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.323800e-02 | 1.199 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.641147e-02 | 1.439 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.024001e-02 | 1.395 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.855710e-02 | 1.314 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.774955e-02 | 1.238 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.928383e-02 | 1.406 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.709169e-02 | 1.243 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.454950e-02 | 1.462 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.217525e-02 | 1.283 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.787401e-02 | 1.238 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.413078e-02 | 1.467 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.663211e-02 | 1.247 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.046180e-02 | 1.219 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.834929e-02 | 1.316 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.340968e-02 | 1.362 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.447814e-02 | 1.352 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.774955e-02 | 1.238 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.394770e-02 | 1.194 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.394770e-02 | 1.194 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.394770e-02 | 1.194 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.394770e-02 | 1.194 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.447814e-02 | 1.352 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.046180e-02 | 1.219 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.406850e-02 | 1.356 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.413078e-02 | 1.467 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.451457e-02 | 1.351 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.894836e-02 | 1.410 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.394770e-02 | 1.194 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.473937e-02 | 1.262 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.196751e-02 | 1.377 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.663211e-02 | 1.247 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.288879e-02 | 1.368 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.894836e-02 | 1.410 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.774955e-02 | 1.238 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.671666e-02 | 1.435 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.024001e-02 | 1.395 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.445750e-02 | 1.264 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.495873e-02 | 1.456 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.350443e-02 | 1.272 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.671666e-02 | 1.435 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.280274e-02 | 1.484 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.428865e-02 | 1.354 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.069807e-02 | 1.295 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.855710e-02 | 1.314 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.041189e-02 | 1.393 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.024001e-02 | 1.395 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.855710e-02 | 1.314 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.787401e-02 | 1.238 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.476388e-02 | 1.349 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.340766e-02 | 1.272 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.433460e-02 | 1.192 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.433460e-02 | 1.192 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.433460e-02 | 1.192 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.517059e-02 | 1.186 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.529510e-02 | 1.185 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.673901e-02 | 1.176 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.754941e-02 | 1.170 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.754941e-02 | 1.170 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.754941e-02 | 1.170 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.780438e-02 | 1.169 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.956044e-02 | 1.158 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.956044e-02 | 1.158 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.956044e-02 | 1.158 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.969506e-02 | 1.157 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.314902e-02 | 1.136 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.582492e-02 | 1.120 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.582492e-02 | 1.120 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.582492e-02 | 1.120 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.582492e-02 | 1.120 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.745452e-02 | 1.111 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.870096e-02 | 1.104 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.870096e-02 | 1.104 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.882164e-02 | 1.103 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 7.882164e-02 | 1.103 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 7.882164e-02 | 1.103 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.882164e-02 | 1.103 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 7.882164e-02 | 1.103 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 7.882164e-02 | 1.103 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.882164e-02 | 1.103 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.953687e-02 | 1.099 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.050273e-02 | 1.094 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.325277e-02 | 1.080 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.504154e-02 | 1.070 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.790493e-02 | 1.056 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.790493e-02 | 1.056 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 8.790493e-02 | 1.056 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 8.790493e-02 | 1.056 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.790493e-02 | 1.056 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.790493e-02 | 1.056 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 8.790493e-02 | 1.056 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.790493e-02 | 1.056 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.790493e-02 | 1.056 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.811123e-02 | 1.055 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.041182e-02 | 1.044 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.041182e-02 | 1.044 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.058250e-02 | 1.043 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.293097e-02 | 1.032 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.293097e-02 | 1.032 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.293097e-02 | 1.032 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.597618e-02 | 1.018 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.656238e-02 | 1.015 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.797550e-02 | 1.009 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.986073e-02 | 1.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.004885e-01 | 0.998 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.005088e-01 | 0.998 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.005088e-01 | 0.998 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.013526e-01 | 0.994 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.029036e-01 | 0.988 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.042928e-01 | 0.982 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.051019e-01 | 0.978 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.051019e-01 | 0.978 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.083042e-01 | 0.965 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.083042e-01 | 0.965 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.089223e-01 | 0.963 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.095640e-01 | 0.960 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.095640e-01 | 0.960 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.095640e-01 | 0.960 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.134469e-01 | 0.945 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.135750e-01 | 0.945 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.135750e-01 | 0.945 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.135750e-01 | 0.945 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.135750e-01 | 0.945 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.146796e-01 | 0.941 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.158745e-01 | 0.936 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.158745e-01 | 0.936 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.158745e-01 | 0.936 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.158745e-01 | 0.936 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.158745e-01 | 0.936 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.158745e-01 | 0.936 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.158745e-01 | 0.936 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.196234e-01 | 0.922 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 1.196234e-01 | 0.922 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.196456e-01 | 0.922 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.196456e-01 | 0.922 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.205009e-01 | 0.919 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.208322e-01 | 0.918 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.230201e-01 | 0.910 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.230201e-01 | 0.910 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.230201e-01 | 0.910 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.260425e-01 | 0.899 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.270460e-01 | 0.896 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.270460e-01 | 0.896 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.270460e-01 | 0.896 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.270460e-01 | 0.896 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.270460e-01 | 0.896 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.270460e-01 | 0.896 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.272443e-01 | 0.895 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.274318e-01 | 0.895 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.300717e-01 | 0.886 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.319918e-01 | 0.879 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.350728e-01 | 0.869 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.364421e-01 | 0.865 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.386849e-01 | 0.858 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.398811e-01 | 0.854 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 1.398811e-01 | 0.854 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 1.404226e-01 | 0.853 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.408684e-01 | 0.851 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.408684e-01 | 0.851 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.408684e-01 | 0.851 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.408684e-01 | 0.851 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.408684e-01 | 0.851 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.408684e-01 | 0.851 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.458593e-01 | 0.836 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.458593e-01 | 0.836 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.458593e-01 | 0.836 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.500678e-01 | 0.824 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.500678e-01 | 0.824 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.505712e-01 | 0.822 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.511503e-01 | 0.821 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.514106e-01 | 0.820 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.514391e-01 | 0.820 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.514391e-01 | 0.820 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.514391e-01 | 0.820 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 1.521830e-01 | 0.818 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 1.521830e-01 | 0.818 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.523293e-01 | 0.817 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.549922e-01 | 0.810 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.549922e-01 | 0.810 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.549922e-01 | 0.810 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.549922e-01 | 0.810 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.549922e-01 | 0.810 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.549922e-01 | 0.810 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.549922e-01 | 0.810 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.549922e-01 | 0.810 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 1.554818e-01 | 0.808 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.603823e-01 | 0.795 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.635335e-01 | 0.786 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.652955e-01 | 0.782 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.662168e-01 | 0.779 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.693708e-01 | 0.771 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.693708e-01 | 0.771 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.693708e-01 | 0.771 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.744799e-01 | 0.758 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.752862e-01 | 0.756 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.755976e-01 | 0.755 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.755976e-01 | 0.755 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.809794e-01 | 0.742 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.836620e-01 | 0.736 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.839610e-01 | 0.735 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.839610e-01 | 0.735 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.839610e-01 | 0.735 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.839610e-01 | 0.735 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.839610e-01 | 0.735 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.855752e-01 | 0.731 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.855752e-01 | 0.731 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.875221e-01 | 0.727 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.875221e-01 | 0.727 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.957432e-01 | 0.708 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.987227e-01 | 0.702 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.987227e-01 | 0.702 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.987227e-01 | 0.702 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.987227e-01 | 0.702 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.987227e-01 | 0.702 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.987227e-01 | 0.702 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.001404e-01 | 0.699 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.001404e-01 | 0.699 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.008663e-01 | 0.697 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.008964e-01 | 0.697 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.012022e-01 | 0.696 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.052737e-01 | 0.688 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.061824e-01 | 0.686 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.136185e-01 | 0.670 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.136185e-01 | 0.670 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.167441e-01 | 0.664 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.183400e-01 | 0.661 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.183400e-01 | 0.661 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.183400e-01 | 0.661 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.183400e-01 | 0.661 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.183400e-01 | 0.661 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.183400e-01 | 0.661 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.183400e-01 | 0.661 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.183400e-01 | 0.661 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.183400e-01 | 0.661 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 2.256852e-01 | 0.646 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.274155e-01 | 0.643 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 2.274155e-01 | 0.643 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.341485e-01 | 0.631 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.343093e-01 | 0.630 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.381838e-01 | 0.623 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.381838e-01 | 0.623 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.436765e-01 | 0.613 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.436765e-01 | 0.613 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.436765e-01 | 0.613 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.436765e-01 | 0.613 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 2.443018e-01 | 0.612 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.487885e-01 | 0.604 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.490366e-01 | 0.604 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.490366e-01 | 0.604 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.497886e-01 | 0.602 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.497886e-01 | 0.602 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.497886e-01 | 0.602 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.497886e-01 | 0.602 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.497886e-01 | 0.602 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.497886e-01 | 0.602 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.497886e-01 | 0.602 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.497886e-01 | 0.602 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.497886e-01 | 0.602 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.497886e-01 | 0.602 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 2.505640e-01 | 0.601 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.587771e-01 | 0.587 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.587771e-01 | 0.587 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.587771e-01 | 0.587 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.587771e-01 | 0.587 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.599618e-01 | 0.585 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.599618e-01 | 0.585 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.722432e-01 | 0.565 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.738882e-01 | 0.562 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.738882e-01 | 0.562 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.738882e-01 | 0.562 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.799738e-01 | 0.553 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.799738e-01 | 0.553 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.799738e-01 | 0.553 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.799738e-01 | 0.553 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.799738e-01 | 0.553 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.799738e-01 | 0.553 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.799738e-01 | 0.553 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.799738e-01 | 0.553 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.799738e-01 | 0.553 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 2.799738e-01 | 0.553 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.799738e-01 | 0.553 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.889845e-01 | 0.539 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.889845e-01 | 0.539 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.889845e-01 | 0.539 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.930569e-01 | 0.533 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.944094e-01 | 0.531 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.957006e-01 | 0.529 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.994013e-01 | 0.524 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.035959e-01 | 0.518 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.040429e-01 | 0.517 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.040429e-01 | 0.517 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.040429e-01 | 0.517 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.040429e-01 | 0.517 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.040429e-01 | 0.517 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.040429e-01 | 0.517 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.041584e-01 | 0.517 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.041584e-01 | 0.517 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.041584e-01 | 0.517 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 3.060247e-01 | 0.514 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.089462e-01 | 0.510 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.089462e-01 | 0.510 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.089462e-01 | 0.510 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.089462e-01 | 0.510 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.089462e-01 | 0.510 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.089462e-01 | 0.510 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.089462e-01 | 0.510 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.089462e-01 | 0.510 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.089462e-01 | 0.510 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 3.172703e-01 | 0.499 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.190419e-01 | 0.496 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.190419e-01 | 0.496 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.339620e-01 | 0.476 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.339620e-01 | 0.476 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.367545e-01 | 0.473 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.367545e-01 | 0.473 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.367545e-01 | 0.473 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.367545e-01 | 0.473 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.367545e-01 | 0.473 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.367545e-01 | 0.473 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.367545e-01 | 0.473 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.367545e-01 | 0.473 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.367545e-01 | 0.473 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.367545e-01 | 0.473 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.367545e-01 | 0.473 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 3.397752e-01 | 0.469 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.434677e-01 | 0.464 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.434677e-01 | 0.464 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.434677e-01 | 0.464 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.486426e-01 | 0.458 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.487854e-01 | 0.457 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.487854e-01 | 0.457 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.487854e-01 | 0.457 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.597366e-01 | 0.444 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.634454e-01 | 0.440 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.634454e-01 | 0.440 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.634454e-01 | 0.440 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.634454e-01 | 0.440 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.634454e-01 | 0.440 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.634454e-01 | 0.440 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.634454e-01 | 0.440 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.634454e-01 | 0.440 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.634454e-01 | 0.440 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.634454e-01 | 0.440 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.634454e-01 | 0.440 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.634454e-01 | 0.440 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.634957e-01 | 0.440 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.634957e-01 | 0.440 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.634957e-01 | 0.440 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.634957e-01 | 0.440 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.634957e-01 | 0.440 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.634957e-01 | 0.440 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.634957e-01 | 0.440 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 3.634957e-01 | 0.440 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.634957e-01 | 0.440 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.647846e-01 | 0.438 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.677516e-01 | 0.434 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.704168e-01 | 0.431 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.708027e-01 | 0.431 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.780779e-01 | 0.422 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.780779e-01 | 0.422 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.780779e-01 | 0.422 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.818327e-01 | 0.418 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.818327e-01 | 0.418 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.890637e-01 | 0.410 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.890637e-01 | 0.410 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.890637e-01 | 0.410 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.890637e-01 | 0.410 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.890637e-01 | 0.410 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.890637e-01 | 0.410 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.890637e-01 | 0.410 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.890637e-01 | 0.410 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.890637e-01 | 0.410 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.890637e-01 | 0.410 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.890637e-01 | 0.410 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.895914e-01 | 0.409 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.916964e-01 | 0.407 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.925187e-01 | 0.406 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.925187e-01 | 0.406 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.925187e-01 | 0.406 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.925187e-01 | 0.406 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.925187e-01 | 0.406 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.925187e-01 | 0.406 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.068058e-01 | 0.391 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.068058e-01 | 0.391 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.068058e-01 | 0.391 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.068058e-01 | 0.391 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 4.068058e-01 | 0.391 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.068058e-01 | 0.391 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.068058e-01 | 0.391 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.077446e-01 | 0.390 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.136526e-01 | 0.383 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.136526e-01 | 0.383 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.136526e-01 | 0.383 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.136526e-01 | 0.383 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.136526e-01 | 0.383 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.136526e-01 | 0.383 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.136526e-01 | 0.383 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 4.136526e-01 | 0.383 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.136526e-01 | 0.383 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.136526e-01 | 0.383 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.162499e-01 | 0.381 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.209282e-01 | 0.376 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 4.237358e-01 | 0.373 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.254466e-01 | 0.371 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.348761e-01 | 0.362 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.348761e-01 | 0.362 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.361900e-01 | 0.360 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.372532e-01 | 0.359 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.372532e-01 | 0.359 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.372532e-01 | 0.359 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.372532e-01 | 0.359 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.372532e-01 | 0.359 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.372532e-01 | 0.359 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.372532e-01 | 0.359 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.372532e-01 | 0.359 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.372532e-01 | 0.359 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.388502e-01 | 0.358 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.434033e-01 | 0.353 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.446161e-01 | 0.352 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.468574e-01 | 0.350 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.475636e-01 | 0.349 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.486406e-01 | 0.348 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.486406e-01 | 0.348 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.502116e-01 | 0.347 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.574431e-01 | 0.340 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.574431e-01 | 0.340 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.599053e-01 | 0.337 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.599053e-01 | 0.337 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.599053e-01 | 0.337 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.599053e-01 | 0.337 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.599053e-01 | 0.337 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.599053e-01 | 0.337 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.599053e-01 | 0.337 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.599053e-01 | 0.337 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.599053e-01 | 0.337 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.599053e-01 | 0.337 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.599053e-01 | 0.337 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.622139e-01 | 0.335 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.622139e-01 | 0.335 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.622139e-01 | 0.335 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.633102e-01 | 0.334 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.755891e-01 | 0.323 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.755891e-01 | 0.323 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.755891e-01 | 0.323 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.789214e-01 | 0.320 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.789800e-01 | 0.320 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.816469e-01 | 0.317 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.816469e-01 | 0.317 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.816469e-01 | 0.317 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.816469e-01 | 0.317 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.816469e-01 | 0.317 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.816469e-01 | 0.317 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.816469e-01 | 0.317 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.816469e-01 | 0.317 | 0 | 0 |
| Acetylation | R-HSA-156582 | 4.816469e-01 | 0.317 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.816469e-01 | 0.317 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.816469e-01 | 0.317 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.816469e-01 | 0.317 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.816469e-01 | 0.317 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.886608e-01 | 0.311 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.886608e-01 | 0.311 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.887602e-01 | 0.311 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.887602e-01 | 0.311 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.988718e-01 | 0.302 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.017220e-01 | 0.300 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.017220e-01 | 0.300 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 5.017220e-01 | 0.300 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.025145e-01 | 0.299 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.025145e-01 | 0.299 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.025145e-01 | 0.299 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.025145e-01 | 0.299 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.025145e-01 | 0.299 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.025145e-01 | 0.299 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.025145e-01 | 0.299 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.025145e-01 | 0.299 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.025145e-01 | 0.299 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.089786e-01 | 0.293 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.089786e-01 | 0.293 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.144699e-01 | 0.289 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.144699e-01 | 0.289 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.144699e-01 | 0.289 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.189776e-01 | 0.285 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.225433e-01 | 0.282 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.225433e-01 | 0.282 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.225433e-01 | 0.282 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.225433e-01 | 0.282 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.225433e-01 | 0.282 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.225433e-01 | 0.282 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.225433e-01 | 0.282 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.270002e-01 | 0.278 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.288655e-01 | 0.277 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.362760e-01 | 0.271 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.386391e-01 | 0.269 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.393097e-01 | 0.268 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.417669e-01 | 0.266 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.417669e-01 | 0.266 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.417669e-01 | 0.266 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.417669e-01 | 0.266 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.417669e-01 | 0.266 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.417669e-01 | 0.266 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.470067e-01 | 0.262 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 5.472027e-01 | 0.262 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.478124e-01 | 0.261 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.482956e-01 | 0.261 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.482956e-01 | 0.261 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.513960e-01 | 0.259 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.513960e-01 | 0.259 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.513960e-01 | 0.259 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.578325e-01 | 0.253 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.602176e-01 | 0.252 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.602176e-01 | 0.252 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.602176e-01 | 0.252 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.602176e-01 | 0.252 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.602176e-01 | 0.252 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.602176e-01 | 0.252 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.602176e-01 | 0.252 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.602176e-01 | 0.252 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.602176e-01 | 0.252 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.602176e-01 | 0.252 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.602176e-01 | 0.252 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.632570e-01 | 0.249 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.632570e-01 | 0.249 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.632570e-01 | 0.249 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 5.632570e-01 | 0.249 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.632570e-01 | 0.249 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.672474e-01 | 0.246 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.672474e-01 | 0.246 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.672474e-01 | 0.246 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.748912e-01 | 0.240 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.748912e-01 | 0.240 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.748912e-01 | 0.240 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.748912e-01 | 0.240 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.748912e-01 | 0.240 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.765382e-01 | 0.239 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.779265e-01 | 0.238 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.779265e-01 | 0.238 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.779265e-01 | 0.238 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.779265e-01 | 0.238 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.779265e-01 | 0.238 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.779265e-01 | 0.238 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.779265e-01 | 0.238 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.779265e-01 | 0.238 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.862978e-01 | 0.232 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.918327e-01 | 0.228 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.949234e-01 | 0.226 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.949234e-01 | 0.226 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.949234e-01 | 0.226 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.949234e-01 | 0.226 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.968800e-01 | 0.224 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.974762e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.974762e-01 | 0.224 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 6.036485e-01 | 0.219 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.084262e-01 | 0.216 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.084262e-01 | 0.216 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 6.084262e-01 | 0.216 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.112367e-01 | 0.214 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.112367e-01 | 0.214 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.112367e-01 | 0.214 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.112367e-01 | 0.214 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.112367e-01 | 0.214 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.112367e-01 | 0.214 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.112367e-01 | 0.214 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.112367e-01 | 0.214 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.112367e-01 | 0.214 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.205954e-01 | 0.207 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.268941e-01 | 0.203 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.268941e-01 | 0.203 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.268941e-01 | 0.203 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.268941e-01 | 0.203 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.268941e-01 | 0.203 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.268941e-01 | 0.203 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.268941e-01 | 0.203 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.268941e-01 | 0.203 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.268941e-01 | 0.203 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.268941e-01 | 0.203 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 6.295869e-01 | 0.201 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.296426e-01 | 0.201 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.399105e-01 | 0.194 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.399105e-01 | 0.194 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.419217e-01 | 0.193 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.419217e-01 | 0.193 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.419217e-01 | 0.193 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.419217e-01 | 0.193 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.419217e-01 | 0.193 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.419217e-01 | 0.193 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.419217e-01 | 0.193 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.419217e-01 | 0.193 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.419217e-01 | 0.193 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.499530e-01 | 0.187 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.499530e-01 | 0.187 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.499530e-01 | 0.187 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.541946e-01 | 0.184 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.543292e-01 | 0.184 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.563450e-01 | 0.183 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.563450e-01 | 0.183 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.563450e-01 | 0.183 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.563450e-01 | 0.183 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.563450e-01 | 0.183 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.563450e-01 | 0.183 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.566042e-01 | 0.183 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.693684e-01 | 0.174 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.693684e-01 | 0.174 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.701882e-01 | 0.174 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 6.701882e-01 | 0.174 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.701882e-01 | 0.174 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.701882e-01 | 0.174 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.733290e-01 | 0.172 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.733290e-01 | 0.172 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.816847e-01 | 0.166 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.834745e-01 | 0.165 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.834745e-01 | 0.165 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.834745e-01 | 0.165 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.834745e-01 | 0.165 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.834745e-01 | 0.165 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.834745e-01 | 0.165 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.854412e-01 | 0.164 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.854412e-01 | 0.164 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.871342e-01 | 0.163 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.871342e-01 | 0.163 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.879033e-01 | 0.162 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.951481e-01 | 0.158 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.962264e-01 | 0.157 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.962264e-01 | 0.157 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.962264e-01 | 0.157 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.962264e-01 | 0.157 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.055758e-01 | 0.151 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.084653e-01 | 0.150 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.084653e-01 | 0.150 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.084653e-01 | 0.150 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.084653e-01 | 0.150 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.084653e-01 | 0.150 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.084653e-01 | 0.150 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.084653e-01 | 0.150 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.202118e-01 | 0.143 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.202118e-01 | 0.143 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.202118e-01 | 0.143 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.202118e-01 | 0.143 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.275880e-01 | 0.138 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.286691e-01 | 0.137 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.314857e-01 | 0.136 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.314857e-01 | 0.136 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.314857e-01 | 0.136 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.314857e-01 | 0.136 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.333904e-01 | 0.135 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.423059e-01 | 0.129 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.423059e-01 | 0.129 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.423059e-01 | 0.129 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.423059e-01 | 0.129 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.423059e-01 | 0.129 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.461238e-01 | 0.127 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.526908e-01 | 0.123 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.526908e-01 | 0.123 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.526908e-01 | 0.123 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.609525e-01 | 0.119 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.609525e-01 | 0.119 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.609525e-01 | 0.119 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.609525e-01 | 0.119 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.626578e-01 | 0.118 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.626578e-01 | 0.118 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.680817e-01 | 0.115 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.680817e-01 | 0.115 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.722237e-01 | 0.112 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.722237e-01 | 0.112 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.722237e-01 | 0.112 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.722237e-01 | 0.112 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.722237e-01 | 0.112 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.722237e-01 | 0.112 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.722237e-01 | 0.112 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.722237e-01 | 0.112 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.722237e-01 | 0.112 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.814046e-01 | 0.107 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.814046e-01 | 0.107 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 7.814046e-01 | 0.107 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.817863e-01 | 0.107 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.817863e-01 | 0.107 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.889509e-01 | 0.103 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.902160e-01 | 0.102 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.913036e-01 | 0.102 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.938848e-01 | 0.100 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.943652e-01 | 0.100 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.943652e-01 | 0.100 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.986727e-01 | 0.098 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.986727e-01 | 0.098 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.986727e-01 | 0.098 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.986727e-01 | 0.098 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.986727e-01 | 0.098 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 7.986727e-01 | 0.098 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.067891e-01 | 0.093 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.067891e-01 | 0.093 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.067891e-01 | 0.093 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.067891e-01 | 0.093 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.129775e-01 | 0.090 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.129775e-01 | 0.090 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.145787e-01 | 0.089 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.145787e-01 | 0.089 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.145787e-01 | 0.089 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.145787e-01 | 0.089 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.187169e-01 | 0.087 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.192069e-01 | 0.087 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.220547e-01 | 0.085 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.292297e-01 | 0.081 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.292297e-01 | 0.081 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.292297e-01 | 0.081 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.292297e-01 | 0.081 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.292297e-01 | 0.081 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.297244e-01 | 0.081 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.361158e-01 | 0.078 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.361158e-01 | 0.078 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.361158e-01 | 0.078 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.427246e-01 | 0.074 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.427246e-01 | 0.074 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.427246e-01 | 0.074 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.490674e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.499491e-01 | 0.071 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.530308e-01 | 0.069 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 8.546518e-01 | 0.068 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.551547e-01 | 0.068 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.551547e-01 | 0.068 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.551547e-01 | 0.068 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.551547e-01 | 0.068 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.551547e-01 | 0.068 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.609968e-01 | 0.065 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.609968e-01 | 0.065 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.609968e-01 | 0.065 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.609968e-01 | 0.065 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.679639e-01 | 0.061 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.719847e-01 | 0.059 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 8.771490e-01 | 0.057 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 8.771490e-01 | 0.057 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.821052e-01 | 0.054 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.821052e-01 | 0.054 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.821052e-01 | 0.054 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.868618e-01 | 0.052 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 8.868618e-01 | 0.052 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.876850e-01 | 0.052 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.944421e-01 | 0.048 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.958078e-01 | 0.048 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.990401e-01 | 0.046 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.990401e-01 | 0.046 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.000123e-01 | 0.046 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.006310e-01 | 0.045 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.014577e-01 | 0.045 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.040474e-01 | 0.044 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.046567e-01 | 0.044 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.065874e-01 | 0.043 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.079199e-01 | 0.042 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.116363e-01 | 0.040 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.136421e-01 | 0.039 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.186259e-01 | 0.037 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.186259e-01 | 0.037 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.250633e-01 | 0.034 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.280888e-01 | 0.032 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.287173e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.338903e-01 | 0.030 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.338903e-01 | 0.030 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.364527e-01 | 0.029 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.364527e-01 | 0.029 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.414817e-01 | 0.026 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.414817e-01 | 0.026 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.414817e-01 | 0.026 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.414817e-01 | 0.026 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.438451e-01 | 0.025 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.461132e-01 | 0.024 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.482898e-01 | 0.023 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.523833e-01 | 0.021 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.543070e-01 | 0.020 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.596249e-01 | 0.018 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.612565e-01 | 0.017 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.654999e-01 | 0.015 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.657667e-01 | 0.015 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.709754e-01 | 0.013 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.721488e-01 | 0.012 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.721488e-01 | 0.012 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.754545e-01 | 0.011 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.799822e-01 | 0.009 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.816197e-01 | 0.008 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.819942e-01 | 0.008 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.830302e-01 | 0.007 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.834797e-01 | 0.007 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.838325e-01 | 0.007 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.874821e-01 | 0.005 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.882129e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.892279e-01 | 0.005 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.904842e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.922613e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.934412e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.935150e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.937070e-01 | 0.003 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.939620e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.939703e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.960453e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.973615e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.977644e-01 | 0.001 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.979714e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.980011e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.983223e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.990243e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.991020e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.997038e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.997386e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.997719e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.998431e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999678e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999945e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999957e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999966e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999980e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |